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Porphyromonas gingivalis is an important etiological agent of periodontal disease 
- a disease that affects an estimated 49,000,000 people in the United States of America. 
Periodontal disease includes gingivitis – inflammation of the gums, and periodontitis – 
destruction of the teeth and their supporting tissues. Porphyromonas gingivalis is 
associated with the chronic form of periodontal disease in addition to several systemic 
diseases. 
The vimA gene of P. gingivalis has been previously shown to play a significant 
role in the biogenesis of gingipains (trypsin-like cysteine proteases). The vimA has also 
been demonstrated to play a role in hemolysis, hemagglutination, autoaggregation, post-
translational protein modification, and LPS biogenesis. Though significant progress has 
been made in characterizing this gene, much remained unsolved prior to this work, 
especially as it relates to the molecular mechanisms and interactions of this protein in 
surface biogenesis, transport and membrane integrity. The focus of our work was to 
clarify the role of VimA on cell surface biogenesis. We were able to show via TEM and 
AFM that there were significant differences between the vimA-defective mutant (FLL92) 
and the wild-type (W83). Particularly, the topography of FLL92 showed numerous fine 
structures compared with W83, and had an irregular, loosely bound capsule. Fimbrial 
synthesis was also affected by the VimA mutation. FimA coupled immunogold particles 
localized with the abundant fimbrial appendages in FLL92, compared with only a few 
 xvii 
adhering in W83. Lectins were used to clarify the effect of the vimA mutation on the 
glycosylation of outer-membrane proteins. Outer membrane proteins glycosylated with 
Galactose (β 1,3) N-Acetylgalactosamine, N-acetyl-α-D-galactosamine, Galactose (β 
1,4) N-Acetylglucosamine, N-acetyl-D-galactosamine and Sialic Acid (N-Acetyl neuramic 
acid) were affected by the vimA mutation. Mass Spectrometric analysis of outer-
membrane and extracellular proteins identified several proteins in FLL92 that were 
aberrantly expressed, missing and of varying abundance. In-silico analysis of VimA 
predicted a likely role as an acyl transferase, with structural similarities to the FemABX 
family of proteins – these proteins are involved in peptidoglycans synthesis. The 
expression profile of lipid modified 3H labeled outer membrane proteins from FLL92 
when compared with W83 was unchanged; however, a 27 kDa protein was observed in 
the extracellular fraction of FLL92 that was twice as abundant in FLL92 as in W83. 
Peptidoglycans isolated from FLL92 were shown to be dissimilar from those isolated 
from W83 via TEM and AFM, with a slower rate of hydrolysis when exposed to 
peptidoglycan specific hydrolytic enzymes. Taken together, we provide evidence that the 
VimA in an important regulator of membrane biogeneis, and is a putative lipid 
transferase.   
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CHAPTER ONE 
INTRODUCTION 
 
Periodontal Disease 
Periodontal disease is the major cause of tooth loss in U.S. adults. Over  50% of 
all American adults have gingivitis on an average of 3 to 4 teeth (107). This disease 
affects the periodontum - the supporting tissue surrounding the tooth (periodontal 
ligament, gingiva, and the alveolar bone). The disease results from the interaction of 
heterogeneous etiological factors; including social and behavioral modulations, genetic 
or epigenetic traits of the host, and formation of a complex subgingival biofilm (53). 
Periodontal disease is initiated by the accumulation of microbial plaque in the gingival 
crevice region; this plaque induces an inflammatory response – gingivitis (mild and 
reversible inflammation of the gingiva – gum).  In certain individuals, this condition may 
progress to a chronic destructive inflammatory stage - periodontitis. This results from a 
complex microbial infection which leads to tissue destruction, resulting from the 
perturbation of the homeostasis between the host defenses and the subgingival 
microbiota (119).  The categories of periodontal disease include: gingivitis, chronic 
periodontitis (or adult periodontitis), general juvenile periodontitis, aggressive 
periodontitis, disease related periodontitis, and acute necrotizing periodontitis (6). 
Periodontitis is irreversible, as it destroys bone and other tooth supporting structures. 
 
Risk Factors for Periodontitis  
The risk factors for periodontal disease include:  smoking, hormonal changes in 
girls/women –makes gums more sensitive and thus increases susceptibility to gingivitis, 
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diabetes – 30% of all diabetics are estimated to have some form of periodontal disease, 
genetic predisposition – 30 % of the population are 6 times more likely than the rest of 
the population to develop the disease (74); medications – some drugs lessen salivary 
flow thus affecting oral health, poor nutrition, stress, and systemic diseases. Periodontal 
diseases have also been implicated in the increased risk of heart attack, increased risk 
of preterm delivery and low weight babies, and increased difficulty in controlling blood 
sugar levels in people with diabetes (29).  
 
Bacterial Etiology of Periodontal Disease 
The bacterial etiology of periodontal disease is rather complex and a variety of 
organisms have been implicated in the initiation and progression of the disease. The 
prevailing view, as supported by the literature, indicates that a number of these disease-
causing microbes are part of the normal flora of a healthy mouth, existing in commensal 
harmony with the host amongst the 350 different bacterial species that are resident in 
the subgingival niche. A disease episode ensues once there is a shift in the ecological 
balance, due to the alteration in the absolute or relative number of certain organisms, 
changes in pathological potential or modulation of particular host factors (Fig. 1.1).  
The progression of adult periodontal disease was initially thought of as a broad 
group of infections with multiple bacterial etiologies; recent evidence however has 
suggested a primary pathogen: Porphyromonas gingivalis. This organism may act either 
alone or in tandem with other putative periodontal pathogens including: Actinobacillus 
actinomycetemcomitans, Fusobacterium nucleatum, Bacteroides forsythus, 
Campylobater rectus, Prevotella intermedia, Treponema denticola, Treponema 
pectinovorum, Selenomonas sputigenam, and Eikenella as part of a mixed infection; and 
possibly in concert with the absence of beneficial species or the immunological 
deficiencies of the host (44,57,82).  
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In response to the bacteria accumulating on the teeth, the host mounts an 
inflammatory response in the gingival tissue, which seeks to remove bacterial products 
such as LPS and proteases that have penetrated the tissue. This inflammatory response 
can also activate matrix metalloproteases - agents of collagen loss in tissues. Elevated 
levels of interstitial collagenase often arise owing to the conversion of latent 
collagenolytic enzymes into their active form by proteases and reactive oxygen species. 
(83-85).  
 Commensal oral Streptococci are the principal early/initial colonizers of the 
salivary pellicle on the coronal tooth surface. Subsequent colonization of additional 
Gram positive along with Gram-negative bacteria occurs only as these initial colonizers 
are established.  As subgingival plaque develops due to the extension of the biofilm 
below the gum line, the colonization of more pathogenic Gram-negative bacteria such as 
P. gingivalis is manifested, and marks a further stage in the disease maturation 
(79,130,154).  
 
Virulence Factors 
A variety of bacterial cell surface components including: capsule, 
polysaccharides, proteases (gingipains), hemmaglutinin, lipopolysacharides, major outer 
membrane proteins and fimbriae contribute to the virulence of Porphyromonas gingivalis 
(82,155).  This organism forms black-pigmented colonies on blood agar plates – due to 
accumulation of -oxo heme dimer on the cell surface (120), is Gram-negative, 
asaccharolytic anaerobe, which is an important etiologic agent of periodontal disease, 
and is also associated with other systemic illnesses including cardiovascular disease 
(28,31,43,98).  
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Fimbriae 
The fimbriae of P. gingivalis consists of a 41-49 kDa and 67-75 kDa cell surface protein 
(depending on the strain) (34,47,49,156). These proteins constitute two distinct sets of 
adhesins/receptors, and are recognized as critical virulence factors which influence the 
initiation and progression of the disease (50). They cooperatively mediate adherence of 
P. gingivalis to oral epithelial cells (61,132,138), salivary components - such as proline-
rich proteins and statherin (5,8,94) and co-aggregation with other bacterial cells (4). The 
major (long) fimbriae are filamentous components on the cell surface. Fimbrillin (FimA) is 
the major subunit protein and mediates bacterial adhesion and colonization in targeted 
sites. Sequence diversity of the fimA gene has been used to classify fimbriae into six 
genotypes (I-V and Ib). The majority of periodontal patients carry P. gingivalis with type II 
fimA organisms; these are associated with the more severe forms of periodontitis 
followed by type IV. In healthy adults, the most prevalent fimA type of P. gingivalis is 
type I. When type II FimA was substituted for type I FimA in the mouse periodontitis 
model, there was increased phagocytosis by macrophages, suggesting that type II 
macrophages interact more efficiently with macrophage phagocytic receptors than type I 
fimbriae (148). The biofilm of Type II FimA also differs from those associated with type I, 
i.e. are more luxuriant and are filled with widely clumped and tall colonies compared with 
type I FimA (78). 
 
Immune Response to FimA 
Human peripheral macrophages and neutrophils have been shown to be induced to 
overproduce several proinflammatory cytokines such as tumor necrosis factor, 
interleukin 1 and interleukin 6 by fimbriae (104). T-cell activation can also be induced by 
fimbriae in mice (60). Major fimbriae is also required for initial entry of P. gingivalis into 
osteoblasts (157). 
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Fig 1.1. Stages in the formation of dental plaque. Colonization of tooth surfaces 
is initiated by bacterial adhesion to the salivary pellicle. Coaggregation and 
coadhesion facilitate the development of multispecies communities. The 
exchange of chemicals between neighboring bacteria promotes co-operation or 
competition. In some cases, communication does not occur until a critical 
biomass is reached. Adherent bacteria produce a matrix of complex 
carbohydrates and/or extracellular nucleic acids, which helps to bind the biofilm 
together and to protect the encased cells. Dental caries or periodontitis arises 
from a shift in the microflora and an accumulation of pathogenic bacteria (63) 
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Fig 1.2. A model for the transport mechanism of the major structural 
proteins of P. gingivalis cell surface filaments. In this model, a 
primary form of the major structural proteins of P. gingivalis cell 
surface filaments is transported from cytoplasm to periplasm via the 
general secretion pathway, where the cysteine residue in the 
lipoprotein box is modified by diacylglyceryl transferase (Lgt). The 
precursor form is then cleaved at the N-side of the cysteine residue 
by signal peptidase II (Lsp). After the major structural proteins are 
transported on to the outer face of the outer membrane, they are 
processed further by Rgp to yield their mature forms, which 
subsequently assemble into filamentous structures. (124) 
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FimA Regulation 
Several environmental cues modulate the expression of the fimA gene; these 
include elevated temperature, hemin concentrations, cell density, serum and salivary 
concentrations (150). There is also evidence to suggest that the FimA can positively 
regulate its own expression (151) through a two-component system which involves the 
fimS and fimR, suggesting multiple mechanisms of regulation control (152). 
At the N-termini of the primary translated forms of fimbrillin and the 75 kDa 
protein is a 10 (34,153) or 46 and 49 amino acid long peptide extension respectively 
(70,108), which is cleaved by arginine specific cysteine proteinase (Rgp). In all six fimA 
genotypes, the first 27 amino acids are the same, suggesting that the prosequence of 
the primary translated protein of fimA is processed sequentially by several peptidases 
(97). The maturation and translocation of fimbrillin and the 75 kDa protein are dependent 
on Signal peptidase II, these proteins are transported to the outer membrane by the 
lipoprotein sorting system, the mature form of FimA is then autopolymerized to form 
fimbriae (124,126) Fig. 1.2.  
 
Mfa Structure and Immunogenicity  
An additional interaction is required for P. gingivalis to accrete to the mixed 
species biofilm. The short fimbriae (mfaI) provides this interaction (124). When viewed 
under the electron microscope, these fimbriae were distinctly short – 5 nm in width and 
0.1 to 0.5 µm in length, compared to the FimA which is 4.6 nm in width and 1.3 µm in 
length (131). The subunit protein of minor fimbriae (Mfa1) is encoded by the mfa1 gene 
(Fig. 1.3.), and the antigenicity and size of the resulting product is different from FimA 
(47,138). The ability of minor fimbriae to elicit an immune response has been 
demonstrated in its ability to induce IL-1, IL-, IL-6, and TNF- cytokine expression in 
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mouse peritoneal (48). Studies with knockouts of fimA, mfa and mfa:fimA inoculated in 
the oral cavities of rats, showed significant suppression of periodontal bone loss when 
compared to the P. gingivalis wild-type ATCC 33277 using the mfa1 and mfa:fimA 
knockouts. More significant bone loss was observed in the fimA knockout than in the mfa 
knockout; additionally, there was no auto-aggregation in the fimA knockout and markedly 
lower levels of adherence to single cells, whereas the double knockout completely lost 
its adhesive capabilities (138).    
The Mfa1 molecule has been shown to be the same as the 75 kDa outer 
membrane protein, the 67 kDa major outer membrane protein, and pg-II (a 72 kDa cell 
surface protein) reported in several studies. Another minor fimbriae has been isolated 
from strain 381 (9) which in contrast to 33277 is 53 kDa and has no immunological cross 
reactivity to the 67 kDa minor fimbriae from 33277 (7). Mfa1 has also been shown to be 
a receptor for SspB (Streptococcal surface polypeptide) BAR, which is necessary for 
optimal coadhesion between P. gingivalis and S. goronii. Antibodies to this protein and 
recombinant Mfa1, competitively inhibited P. gingivalis – S .gordonii binding; additionally, 
recombinant Mfa1 was found to bind SspB BAR peptide in a dose dependent manner 
(112). The degree of P. gingivalis aggregation was found to correlate with the expression 
levels of mfa1 and fimA. In particular, the down-regulation of fimA and the up-regulation 
of mfa1 are believed to bring about autoaggregation of P. gingivalis; additionally, minor 
fimbriae appears to play an important role in microcolony formation by facilitating cell-cell 
interactions and the maturation of monospecies biofilms (88). 
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Fig 1.3. Schematic diagrams of the downstream genes of fimA (A) and mfa1 (B) 
in limited strains. (A) The top line shows the FimA gene cluster of 
Porphyromonas gingivalis ATCC 33277 and 381 (fimA genotype I). Below are 
P. gingivalis W83 (genotype IV) and OMZ314 (genotype II). Open-reading frames 
are represented by arrows indicating their 3′ ends. The fimA sequences of ATCC 
33277, W83 and OMZ314 were obtained from GenBank (D42067) and TIGR 
GenBank (AB261607), respectively. The downstream sequence of fimD in 
OMZ314 is indicated by a box with a broken line; the sequence further 
downstream is not yet available. W83 does not produce FimA fimbriae, partly 
because of a defect in FimSR, a two-component signal transduction system, 
positively regulating their production. (B) A potential mfa1 gene cluster in ATCC 
33277 and W83. The gene cluster appears to be composed of at least five 
genes, including mfa1, with the same transcriptional direction except that mfa1 is 
split into pg0176 and pg0178 by ISPg4 (pg0177), indicated by the solid arrow, in 
W83. Therefore, W83 does not produce Mfa1 fimbriae either. The gene fimB 
(and its corresponding genes) and mfa2 (and its corresponding gene) are 
highlighted as hatched arrows in FimA and Mfa1 gene clusters, respectively. The 
number values shown under the genes indicate their lengths in bp (155). 
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Hemagglutinin 
Hemagglutination in P. gingivalis is a distinctive property, which differentiates it 
from other asaccharolytic, black pigmented anaerobes, and is essential for its growth 
(99). Hemagglutination is related to the ability of the bacteria to adhere to host cells, and 
is particularly significant since P. gingivalis grows faster in cultures with hemin than in 
cultures without hemin (118). Hemin accumulation by P. gingivalis directly affects its 
pathogenicity, exemplified by the decrease in transcripts of hemagglutinating genes (86) 
gingipain enzyme activity (73), and promoter activity of fimbriae gene (150) under hemin-
limited growth conditions. There are several reported genes that have been 
demonstrated to encode hemagglutinin domains, these included: rgpA(HagE), kgp, 
(30,100) , hagA, hagB, hagC (86) and hbp35 (55,56,136). Mutants of rgpA, kgp and 
hagA, showed decreased abilities to agglutinate erythrocytes, while an rgpA-kgp-hagA 
triple mutant had no hemagglutinating activity (100,123). 
 
Hemagglutinin Domains  
The adhesion domain coded for by hagA is similar to that encoded for by the 
carboxy terminal regions of rgpA and kgp.  These adhesin domains are involved in cell 
induced hemagglutination as well as platelet aggregation (96,118). Conversely, hagB 
and hagC share over 90% homology, in contrast to only 40% with their upstream and 
downstream regions (86). HA-Ag2 a cell bound hemagglutinating adhesin, was identified 
as one of the common antigens of the species; H1 of HA-AG2 is hemmaglutinin specific 
while the F2 domain is fimbriae specific (17). The recombinant form of Hgp44 located 
between Ser720 and Arg1138 of RgpA, and present in Kgp and HagA , was 
demonstrated to possess the ability to agglutinate erythrocytes, this residue has multiple 
domains including Hgp44B which induces hemagglutination, and Hgp44A which likely 
functions as a suppressor of hemagglutination – also has the hemagglutinating epitope 
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(GVRSPEAIRGRIQGWRQKT) (100) Fig. 1.4. The Hgp44 domains of HagA, RgpA and 
Kgp have also been shown to be key adhesion factors for the coaggregation between P. 
gingivalis and T. denticola (62). Using phase displayed epitope mapping, a functional 
domain of hemagglutination - IALDQTLGIP - was identified in HBP35. The mutant of  
HPP35  was non black pigmented, showed decreased autoaggregation and 
coaggregation with other bacteria, and had reduced gingipain activity(55).  
 
Hemagglutinin Immunogenicity 
Immunoglobulin G (IgG) antibody was demonstrated to react with recombinant P. 
gingivalis hemagglutinin with both chronic and generalized aggressive periodontitis 
patients. Most of this IgG belonged to the IgG1 and IgG3 subclasses. Interestingly, there 
was no relationship with measures of periodontal attachment loss (15). Other studies 
have demonstrated that IgG2a and IgG2b, both of which are complement fixing are the 
predominant IgG subclass induced by HagB (76). HagB has been demonstrated to 
adhere to Human Coronary Artery Endothelial Cells  (HCAE) (133), the purified form has 
also been found to elicit a protective immune response in the rat bone loss model (72). 
Immunization with Hgp44 also provided protective effect against P. gingivalis induced 
alveolar bone loss (93). Nasal immunization with the antigenic region of HagA fused to a 
Maltose-Binding protein in mice was effective in eliciting IL-4 and IL-5 producing Th2-
type CD4+ T cells for the induction of serum IgA, IgG, and mucosal IgA antibody 
responses. These specific immune responses provided protective immunity against 
alveolar bone loss caused by P. gingivalis infection (36). 
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Fig 1.4. Inhibitory effect of the so-called hemagglutinating epitope on the 
hemagglutinating activity of Hgp44 during transport of gingipain proproteins. 
Gingipain proproteins are transported from the cytoplasm to the periplasm 
by the Sec-dependent pathway and secreted from the periplasm to the cell 
surface by the Por secretion system. (The so-called hemagglutinating 
epitope is removed from the proproteins after translocation to the cell 
surface. cp, C-terminal portion of prosequence; IM, inner membrane; np, N-
terminal portion of prosequence; OM, outer membrane; pro, prosequence; 
sp, signal peptide (99). 
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Lipopolysaccharides 
The lipopolysaccharides of P. gingivalis, were initially demonstrated to have 
significantly different low endotoxic properties when compared to enterobacterial LPS 
(95), and it was postulated that this difference in endotoxic potency was dependent on 
the chemical structure of it’s lipid A. Compositional analysis of the LPS revealed that the 
polysaccharide component consisted of rhamnose, glucose, galactose, mannose, 
glucosamine and galactosamine (14). P. gingivalis has a novel lipid A structure when 
compared to enterobacterial and B .fragilis lipid A. In particular, the backbone of this lipid 
A was found to consist of a phosphorylated -(1-6) linked glucosamine disaccharide at 
the 1 position of the reducing sugar, additionally the structure lacked an ester linked 
phosphate group bound to the hydroxy group at the 4’ position of the nonreducing sugar. 
This unique structure was believed to contribute to the mitogenic effects noted on 
splenocytes in C3H/HeN and C3H/HeJ mice (103). LPS was further demonstrated to be 
comprised of two macromolecules containing different glycan repeating units: O-LPS 
(with O-antigen tetrasaccharide repeating units) and A-LPS (with anionic polysaccharide 
repeating units) (110).  
 
O LPS 
The core oligosaccharide (OS) of O-LPS occurs in two glycoforms: a capped 
core containing the site of O polysaccharide attachment and an uncapped form devoid of 
O polysaccharide. This core OS of P. gingivalis O-LPS is a highly unusual structure 
(109). The O antigen polymerase (OS1142) was shown to differ from the O antigen 
ligase (OS1051) by up to 5 additional α-(13)-linked mannose residues attached to the 
nonreducing terminal residue of α-mannose at position 4 of the main outer core 
glycoform, which forming a capped core. It is believed that the actions of α-1,3 –
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mannosidase (PG1711) may be important for generating the uncapped core from the 
capped core or alternately a manosyltransferase (PG0129) may add additional  α-1,3 
linked Man residues to the shorter uncapped core to generate the capped core (109). 
 
A-LPS 
The APS is comprised of a phosphorylated branched D-Man-containing oligomer 
composed of an 16- linked D mannose backbone to which 12 linked D-Man side 
chains of different lengths at position 3 are attached. It has been suggested that the 
synthesis of APS occurs via a wzy (polymerase)-dependent pathway in which 
polymerization of repeating units formed on the cytoplasmic face of the inner membrane, 
occurs after they are transported or flipped across the cytoplasmic membrane to the 
periplasmic face. PG1142 has been shown to be the sole polymerase capable of 
polymerizing the O-antigen repeating unit in P. gingivalis (111). The final step in the 
assembly of these two different macromolecules is catalyzed by a relaxed-specificity 
ligase named WaaL, which is able to attach either a tetrasaccharide repeating unit or a 
branched phosphorylated mannan to the lipid A core (114). Recombinant Kgp-RgpB-
Myc proteins were shown to bind to the LPS fraction of wild-type P. gingivalis in vitro, 
suggesting that gingipains may be anchored to the cell surface through surface 
polysaccharides (120).   
 
LPS Maturation 
Several genes have been implicated as being involved in the formation of 
extracellular polysaccharides and glycan additions of gingipain-adhesin complexes –
vimA, vimE, vimF, porR, rfa and ugdA (105,110,120,125,141-143) these mutants lose 
colonial pigmentation and show no reactivity to MAb 1B5 (monoclonal antibody which 
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react specifically with the modification Manα1-2Manα1-phosphate side chain) (109). 
Increased sensitivity to serum killing was observed in APS biosynthesis defective mutant 
strains (128). LPS was also found in great abundance in membrane vesicles, these 
packaged LPS were capable of penetrating periodontal tissue and eliciting a destructive 
host induced immune response (46,92). There is evidence to suggest that LPS 
maturation may be linked to a novel PorS secretion system, which includes the Por 
family of proteins in addition to LptO which directly effects lipid A structure through 
deacylation (18) Fig. 1.5.  
 
LPS Immunogenicity 
P. gingivalis LPS has also been shown to activate human monocytes by a CD14-
dependent mechanism, it has also been demonstrated to activate both human and 
mouse TLR2 and TLR2 plus TLR1, as well as TLR4 in transiently transfected cells 
expressing mCD14 (25). TLR2–mediated cell activation is believed to occur through a 
lipoprotein from the LPS (51). In endothelial and oral epithelial cells challenged with 
commercially prepared LPS, several cytokines were produced, in particular: IL- and IL-
6 in addition to molecules involved in the adhesion of leukocytes to inflammatory sites: 
IP-10, MIP-1, ,  ICAM-1 and M-CSF (75). 
 
Gingipains 
P. gingivalis produces a novel class of cysteine proteases termed Arg-
gingipain/Arg-X (Rgp) and Lys-gingipain/Lys-X (Kgp) on the basis of their peptide 
cleavage specificity at arginine or lysine residues respectively (113). These enzymes are 
virulence factors that serve to disrupt the normal host defense mechanism in addition to 
their proteolytic destruction of host connective-tissue proteins, including collagen (type I 
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and IV) and extracellular matrix proteins such as fibronectin and laminin 
(3,12,71,129,134) (Fig. 1.6.). Arg-X is encoded by two separate genes (rgpA and rgpB), 
while Lys-X is encoded by a single gene (kgp) (101). 
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Fig. 1.5. Proposed role of LptO in a model of the co-ordinated secretion and 
attachment of A-LPS and CTD proteins at the cell surface. In this model it is 
proposed that lipid A is synthesized in the cytoplasm and linked to the core 
oligosaccharide. It is then flipped across the IM by MsbA (PG1719) (Step 1). 
The WaaL ligase (PG1051) then attaches either O-antigen or APS (Step 2). 
The newly formed LPS is dephosphorylated by lipid A phosphatase (PG1587 or 
PG1773) located in the IM (Step 3). The Lpt IM complex (PG0628, PG0501 and 
possibly PG0598) detaches the LPS from the IM, and may pass it to a 
periplasmic carrier (possibly PG0414) (Step 4), which is thought to be LptA in 
E. coli. The Lpt OM complex including PG1405 the putative LptD (Step 5) flips 
A-LPS to the outer surface of the OM (Step 6) where it can be deacylated by 
LptO (PG0027) with the released fatty acid chain recovered by lateral diffusion 
through the pore of LptO (Step 7). The deacylated A-LPS is inserted into the 
OM and conjugated to secreted CTD protein in a co-ordinated secretion event 
that involves PorSS (Step 8). (18) 
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Different Forms of Gingipains 
Three enzyme species make up the extracellular Arg-x protease activity in P. 
gingivalis W50 – hRrgpA (heterodimer in which the catalytic chain is noncovalently 
associated with an adhesin chain, 54 kDa), RgpA (free monomeric catalytic chain) and 
mtRgpA (membrane type RgpA which is exclusively identified with the membrane 
fraction, 70-80 kDa). RgpB lacks the adhesin coding region of the adhesin chain of 
RgpA, and closely resembles the monomeric protease derived from rgpA. RgpB is found 
in two forms – RgpB and mtRgpB (21,37,38,115). RgpA and mt-RgpA were 
demonstrated to be glycoproteins, isoforms of RgpA and RgpB were found to react 
differently with MAb 1B5, in particular RgpA, mt-RgpA and RgpB reacted strongly with 
MAb, while no reactivity was observed with HrgpA or RgpB. RgpA was also 
demonstrated to possess 20 – 30% (by weight) carbohydrates (23). RgpA was shown to 
contain several sugars of varying abundance including: Ara, Rha, Fuc, Man, Gal, Glc, 
GalN(Ac), GlcN(Ac) and N-acetylneuraminic acid (NANA) which totaled 14.4% by weight 
of protein, while HrgpA totaled 2.1% by weight of protein (Table 1.1.). RgpB isolated 
from P. gingivalis W50 rgpA isogenic mutant was found to contain Ara, Rha, Fuc, Gal, 
Glc, GlcA and GlcN(Ac) which totaled 10% by weight of protein (23). 
 
Role of Gingipains in the Host Cellular Response 
Gingipains are involved in several cellular processes (80) including: growth, 
inactivation of cytokines and their receptors, platelet aggregation, attenuation of 
neutrophil antibacterial activities, increasing vascular permeability and apoptosis of 
gingival epithelial cells (135). It has also been suggested that protease activity may play 
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Fig. 1.6. Native proteins degraded by Rgp and Kgp and the relation of 
degradation to pathogenicity (69). 
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a role in oxidative stress resistance, hemoglobin binding, absorption and heme 
accumulation (2,44).  
The ability of gingipains to disrupt the host defense mechanism is clearly 
demonstrated by their ability to degrade and inactivate immunoglobulins such as IgG, 
IgA and secretory IgA and cytokines including TNF and interleukin 6 (10,16). The 
generation of radical oxygen species from activated polymorphonuclear leukocytes is 
also inhibited by Rgp and Kgp, suggesting that these proteinases can impair cellular 
components of the defense mechanisms (3,71).  
 
Structure of Gingipains 
Based on the similarity of the nucleotide sequences, the rgpA and kgp genes can 
be divided into six DNA regions. Little similarity is observed between kgp and rgpA in the 
P region, which includes the prepropeptide and most of the proteinase domain. The CP 
region follows the P region and corresponds to the carboxy terminal region of the 
proteinase domain. There is 94% identity between rgpA and kgp in this region. There is 
also close homology between the A2 and A4 regions that cover most parts of the 
carboxy-terminal adhesin domain and shows close similarity (98 and 96% respectively). 
The presence of several nucleotide repeats in the carboxy-terminal domain is believed to 
facilitate rearrangements (Fig. 1.7.) (69).  
The inability of MAb 1B5 to recognize C terminally truncated RgpB (48 to 50 kDa) 
(22,40), led to the suggestion that the carbohydrate modification recognized by the MAb 
1B5 is in the C terminal domain, and may play a role in the outer membrane attachment 
of the enzyme (145). Numerous outer membrane proteins were found to have primary 
and secondary structure similarity to the C-terminal domain of RgpB, and were 
designated as CTD family; members of this family are attached to the cell surface 
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through cell envelope glycans, which are important for proper folding and processing in 
order to produce a fully functional enzyme (122). 
 
Gingipains as Processing Enzymes 
Arg-X was found to be a major processing enzyme of several outer membrane 
proteins including fimbrillin, as it was able to convert prefimbrillin to the mature fimbrillin 
in vitro, interestingly the Lys-X was also shown to be abnormally processed in the Rgp 
null mutant, suggesting that Arg-X may be involved in the maturation process of Lys-X 
(70). There is also evidence to suggest that Arg-X is induced under iron poor conditions 
but down regulated under iron rich conditions (137). 
 
Capsule 
Encapsulated P. gingivalis has been demonstrated to cause serious forms of 
infection;  and mice challenged with encapsulated P. gingivalis develop more severe 
infections than those challenged with unencapsulated strains (81,139). Capsular 
polysaccharides (CPS) (or K-antigens) consists of several sugars including: 
galactosamine, glucosamine, glucose, galactosaminuronic acid, mannuronic  
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Table 1.1. GC-MS analysis of O-TMS ethers of methyl glycosides showing the molar 
ratios of monosaccharides in the oligosaccharides of HRgpA, RgpA, and LPS of P. 
gingivalis W50 after methanolysis (23). 
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Fig. 1.7. Isoform construction by proteolytic processing and assembly of the 
translated products of rgpA, rgpB, and kgp genes (HG66). Open arrows denote 
translation of gingipain genes to their proforms. Pro, profragment;  Catalytic, 
catalytic domatin; HA1, HA2, HA3, HA3/4, HA4, hemmaglutinin/adhesin 
subdomains. Inistial and end amino acids of domains are shown. Small numbered 
arrows denote the cleavage site amino acid numbers and large arrows denote 
proteolytic processing and assembly of the mature enzyme complex, respectively. 
The domains with high homology are shown in the same pattern and the 
percentage above Pro-Kgp columns denotes homology percentage of the Pro-Kgp 
domains for the corresponding Pro-HRgpA domains. Dots attached to mt-RgpA 
and mt-RgpB denote polysaccharide chains. Molecular weights of isoforms are 
shown in parentheses. (Modified from Potempa et al. (59) 
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acid, glucoronic acid and 2 acetamido-2-deoxy-D-glucose (41,121). Six serotypes have 
been identified in P. gingivalis (K1 to K6) in addition to several strains that are K- (devoid 
of a capsule). Adhesion of P. gingivalis to human pocket epithelial cells depends on the 
hydrophobicity of the bacteria, which is lowered by the presence of a capsule. Cells 
deficient in capsule have a higher adherence to epithelial cells and show increased auto-
aggregation, and are usually fimbriated - show peritrichous fimbriae on their surface in 
contrast to the poorly adherent strains, which have significantly less fimbriae and are 
shorter than well adhering strains (35,77,139,149). There are significant variations 
between all six serotypes and limited conservation as revealed by restriction fragment 
length polymorphism analysis. DNA sequence analysis of the K-antigen locus of 381 
which is syntenic with W83 revealed that pg0109-pg0114 may be important for capsular 
expression (39). It was later determined that several essential genes including pg0106 
as well as HU (small, basic, heat stable DNA binding protein) are also necessary 
capsular expression (Fig. 1.8.). Interruption of pg0106 prevented capsular 
polysaccharide synthesis as well as attachment and initiation of biofilm formation in vitro 
(11,29).  
 
Immunogenicity of the Capsule 
CPS from P. gingivalis serotype K5 are able to bind F. nucleatum cells, and are able 
to inhibit coaggregation between these two oral bacteria (116), while K1 capsular 
polysaccharides have been shown to elicit chemokine production from phagocytic cells 
and may be important for establishing the inflammatory lesion observed during 
periodontal disease (24). All serotypes of P. gingivalis were able to induce a T-helper 
type 1 (Th1) pattern of cytokine expression. Dentritic cells (DCs) stimulated by K1 and 
K2, expressed higher levels of IL-1β, IL-6, IL-12p35, IL-12p40, and IFN-γ at lower 
multiplicity of infection (MOI) than DCs stimulated with other strains (146). Vaccination 
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with P. gingivalis  CPS in the murine model prevented oral bone loss elicited by P. 
gingivalis oral challenge (45). 
 
Heme Transport 
Iron in the form of hemin is one of the growth requirements for P. gingivalis, this 
organism is able to metabolize a broad range of hemin substrates including 
methemoglobin, myoglobin lactoperoxidase, and catalase (13). Owing to the toxic nature 
of unregulated iron, i.e. is a cofactor for the generation of oxygen radicals from peroxide, 
which can contribute to the oxidative stress, encountered by the bacteria; levels of iron 
are tightly regulated in bacteria, to provide adequate iron for bacterial growth while 
limiting its availability for interaction with peroxide. P. gingivalis does not utilize the 
protoporphyrin IX synthetic pathway, rather it uses hemin as a cofactor for fumarate 
reductase and cytochromes  It must therefore acquire hemin from its environment (106). 
Several uptake pathways are utilized for hemin uptake; these include the htr/tlr (127), 
hmu (87) iht (27), and a ferrous uptake transporter – FeoB (26,102). 
 
Htr/Tlr Transporter 
The htr/tlr locus consists of 5 genes – htrA (periplasmic binding protein), htrB 
(permease), htc (ATP binding protein), htrD (unknown function) and tlr (TonB linked 
receptor). The htrABCD have sequence similarity to heme transport systems of other 
bacteria while the tlr gene has been demonstrated to be essential for growth at low 
hemin concentrations. A preprotein is encoded by the tlr gene. At the N terminus of this 
Tlr protein is a TonB Box I and Box III motif, these are typical of TonB linked outer 
membrane receptors in gram negative bacteria (127). 
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Fig. 1.8. Schematic representation of the capsule locus. (A) The position of the 
predicted hairpin structure created by base pairing of the 77-bp inverted repeat 
is indicated as a segmented line, and predicted promoter regions are shown 
with black arrows. The number of base pairs on either side of the hairpin and 
those contained within the loop are indicated. The ORF numbers correspond to 
TIGR CMR identifications. (B) Sequence and alignment of the 77-bp inverted 
repeat (11). 
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Hmu Transporter 
The hmu locus is composed of six genes, hmuYRSTUV; these encode a novel 
hybrid haemin-uptake system. Notably, hmuY encodes a 23kDa iron-repressible outer- 
membrane protein which is upregulated in iron depleted conditions in addition to the 
hmuSTUV portion which consists of a putative cobalamin biosynthesis 
(CobN)/magnesium chelatase (HmuS), two putative proteins with predicted 
transmembrane domains (HmuT and HmuU) (87). 
 
Iht transport 
The iht (iron heme transport) locus is comprised of five genes – ihtA (TonB linked 
receptor), ihtB (accessory lipoprotein), ihtC (periplasmic binding protein), ihtD 
(permease) and ihtE (ATP binding protein) iron heme transport). IhtB has sequence 
similarity to the CbiK of S.typhimurium, which is an anaerobic cobalt chelatase. IhtB 
contains 13 of the 14 conserved residues that are present in the PPIX ferrochelatase 
anaerobic cobalt chelatase class, and has active site residues typical of chelatases. A 
substantially increased lag time was observed with heme limited P. gingivalis incubated 
with heat inactivated IhtB peptide-specific antiserum prior to inoculation in a medium 
containing hemin. This supported the view that IhtB is involved in iron transport into the 
cell (27). 
 
FeoB1 Transporter 
P. gingivalis has two feoB genes – feoB1 is monocistronic and encodes a protein 
of 844 amino acids, the second feoB2 encodes a 725 amino acids. Both proteins share 
over 30% identity and 50% similarity with E.coli FeoB, and their genes were transcribed 
under excess heme condition with a second gene, pg1296 and mntR, respectively. 
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Whereas inactivated feoB2 had no effect on radiolabeled iron uptake, feob1 inactivation 
abolished the transport of radiolabeled iron and resulted in a 2-fold decrease in cellular 
iron, when grown under excess heme conditions. Additionally, inactivated feob1 in a 
murine lesion model of infection rendered the bacterium avirulent, in contrast to the 
feob2 mutation, which induced lesions with no significant difference in size (26). 
 
Oxidative Stress 
P. gingivalis possesses a low tolerance to oxygen when compared to other 
anaerobes (33), though incapable of colony formation on plates incubated aerobically, it 
can tolerate aerobic conditions and can grow in the presence of oxygen at 
concentrations lower than in air. The presence of a heme rich environment increases its 
aerotolerance. When P. gingivalis was grown under an oxygenated environment, there 
were accompanying changes in cell morphololgy – bacillary when stressed as opposed 
to coccoid, antioxidant enzymes – NADH oxidase, NADH peroxidase and SOD 
increased under oxygenated conditions, proteinase activity – Rgp whole cell activity 
increased while Kgp whole cell activity decreased, and fermentation end-products (32). 
The FeoB1 transporter was demonstrated to impart peroxide sensitivity to 
microbial cells. Cells deficient in FeoB1 showed a 40% to 70% reduction in their ability to 
grow in the presence of peroxide (102).  Similarly in knockouts of the aphC (alkyl 
hydroperoxide reductase) which has peroxide scavenging activity, the mutant showed 
increased sensitivity to hydrogen peroxide, but exhibited no change in its pathogenic 
potential (65). P. gingivalis produces an Rbr-like protein (rubrerythin) which is induced 
above its constitutive anaerobic level in response to dioxygen or hydrogen peroxide. 
Strains with disrupted rbr showed increased oxidant sensitivity (33). SOD (superoxide 
dismutase) expression is dependent on specific environmental conditions; these include 
increased temperature, oxygen and alkaline pH. Though this enzyme is crucial to the 
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survival of the organism in aerobic environments as well as conditions generated by 
specific reactive oxygen species (ROS), it does not protect the organism against 
exogenously generated superoxide or human neutrophils (91). 
 
The recA Locus 
BCP Plays a Role in Oxidative Stress 
The recA locus consist of 6 putative genes – bcp (0.5 kb), recA (1 kb), vimA (0.9 
kb), vimE (1.3 kb), vimF (1.2 kb) and aroG (1.1kb), that is part of a single transcriptional 
unit. Bacterioferritin co-migratory protein (Bcp) has in several organisms been shown to 
play a role in oxidative stress resistance (20,54,147). It belongs to the thiol-specific 
antioxidant/alkyl hydroxyperoxidase family, detoxifying hydrogen peroxide in a similar 
way to the AhpC (64). The bcp defective mutant from P. gingivalis W83 designated 
FLL302, showed increased sensitivity to hydrogen peroxide at concentrations of 0.25mM 
when compared to the wild-type, was black pigmented like the parent strain and had 
similar rates of hemolysis,  hemolysis and UV sensitivity. This isogenic mutant also 
showed a 30% reduction in Arg-X and Lys-X activity during late exponential growth 
phase. There was also no detectable difference in the virulence potential of the bcp 
defective mutant when compared with the parent strain in the murine mouse model and 
demonstrated decreased aerotolerance when compared with the wild-type (67).  
 
RecA is Involved in DNA Repair in P. gingivalis 
The recA of P. gingivalis is involved in DNA repair, and the deduced protein 
shows high similarity to the other Gram-negative anaerobes (42). The recA isogenic 
mutant (FLL32) is non black pigmented and has no detectable β-hemolysis on brucella 
blood agar plates, in contrast to wild-type W83 (parent strain), which is black pigmented 
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and hemolytic. Additionally, the recA mutant showed increased sensitivity to ultraviolet 
radiation and had reduced Arg-X and Lys-X specific proteolytic activities, though the 
transcription of these genes was unaffected. Monospecific, polyvalent antibodies against 
the gingipains identified them in the extracellular medium and suggest a difference in the 
processing of these proteases. This mutant was also significantly less virulent than the 
wild-type in the murine model and provided partial protection to animals against a 
subsequent lethal challenge by the wild-type strain. There was also increased 
autoaggregation of this mutant, suggesting changes in the surface membrane proteins 
(2). Using in vitro expression technology (IVET) with pFLL115 (suicide vector containing 
erythromycin/clindamycin resistance gene and the promotorless xa-tetA (Q) 2 cassette, 
it was demonstrated that the recA gene was expressed during infection of the murine 
host (89). The effect of environmental signals on recA promoter activity was examined 
using a transcriptional fusion of the recA promoter region with pFLL115. Exposure to 
agents that induce DNA damage did not elicit a change in reporter activity, which 
remained constant, suggesting that the recA is not controlled by an inducible SOS-like 
regulatory system (as observed in E. coli). Growth phase and pH changes had no effect 
on recA activity. In contrast, changes in temperature, calcium concentration and iron 
levels resulted in significant changes to the recA gene expression levels (90). 
 
Virulence Modulating Gene A 
The vimA gene (virulence modulating gene A) is downstream of recA and codes 
for a unique 32 kDa protein. When this gene was inactivated by allelic exchange, the 
resulting phenotype of the stain (FLL92) was non black pigmented, has reduced Arg-X 
and LysX specific proteolytic activity, lacked beta hemolytic and hemagglutinating 
activities, showed increased autoaggregation and was nonvirulent when tested in the 
murine mouse model. The reduced gingipain activity was not associated with changes in 
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the transcription levels of the gingipain genes (1). This is further supported by the 
presence of the proenzyme form of the gingipains (105). There was also a late onset of 
gingipain activity in FLL92 which was mostly soluble, and had little or no cell-associated 
activity (105,143). The recombinant VimA can interact with the gingipains (Fig. 1.9.) in 
addition to several proteins, including HtrA, β-lactamase, sialidase and RegT, which are 
known in other bacterial systems to be involved in post-translational regulation Table 
1.2. (144). There are 26 amino acid residue of VimA on HtrA and hypothetical protein 
PG1833, which may be a direct site of protein interaction. Sera from animals immunized 
with P. gingivalis were able to recognize VimA, suggesting that the immune system is 
exposed to VimA during the course of an infection (144). 
 
Virulence Modulating Gene E 
The vimE gene is downstream of vimA and is expressed independently of vimA. 
The isogenic mutant of this gene (FLL93) resulted in a phenotype that showed reduced 
Arg-X and LysX specific proteolytic activities that unlike FLL92 was not affected by the 
phase of growth. A defect in gingipain biogenesis similar to FLL92 was supported by the 
presence of the mRNA transcript for the gingipain genes. A 64-kDa immunoreactive 
band similar to that observed in FLL92 was observed in FLL923, using antibodies 
against the RgpB proenzyme. Dansyl-glutamyl-glycyl-arginyl chloromethyl ketone (DNS-
EGR-CK), which irreversibly binds the Rgp active site of Arg-X proteases in wild-type P. 
gingivalis and FLL92 cells grown to stationary phase, did not label any protein similar in 
size to the expected 48-kDa fluorescent band in FLL93 (141).  
 
Virulence Modulating Gene F 
The VimF protein coded for by the vimF gene is a putative glycosyltransferase. 
The phenotype of the isogenic mutant (FLL95) is similar to that of FLL93, i.e. has 
 32 
reduced gingipain, hemagglutinating, and hemolytic activity. The gingipains unlike that 
observed in FLL92 are membrane and extracellular associated. The membrane forms 
are of high molecular weight; these represent the unprocessed or partially processed 
gingipains. Additionally, no immunoreactivity was observed with MAb 1B5 (monoclonal 
antibody specific for carbohydrate modifications of membrane associated Rgp and LPS). 
Several high molecular weight bands greater than 191-kDA were also observed in the 
membrane fraction of FLL95 and FLL93, and represent unprocessed or partially 
processed HagA species. This suggests that vimF may be necessary for proper 
processing of the hemmaglutinin protein.  Fibronectin (plays an important role in cellular 
signal transduction by interacting with integrins) was cleaved at significantly lower levels 
when incubated with the vimF and vimE, when compared to W83, which completely 
degrades fibronectin. Significantly, the vimA defective mutant was unable to cleave 
fibronectin, and it has been suggested that the reason for this may be due to absence of 
Kgp and RgpA on the surface of the cell (142).  
 
The recA Locus and Adhesion 
The effect of protease active extracellular protein preparations from P. gingivalis 
on the adhesion properties of human epidermoid carcinoma KB cells, demonstrated that 
extracellular protein preparations with gingipain activity induced cell rounding and 
detachment from each other and from the surface of the culture dish. The level of cell 
death was found to be correlated with the protease-dependent activities of the isogenic 
mutants tested (FLL32 and FLL33). Interestingly, the kinetics of N-cadherin cleavage 
and loss of cell adhesion was different in FLL32 and FLL33. Preparations from FLL32 
(low gingipain activity) did not induce the cytotoxic effects observed for P. gingivalis 
FLL33 and W83. The levels of integrin 1 in FLL33 preparations remained unchanged in 
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the first 12 hours of exposure to P. gingivalis FLL33 preparations, however at 24 hours a 
decrease in the intensity of the integrin 1 was observed.  There were also statistically 
significant moderate levels of apoptotic cell death during long-term incubation of KB cells 
with extracellular protein preparations from P. gingivalis; suggesting that gingipain 
induced cell death may contribute to tissue destruction typical of periodontal disease 
(19). 
 
Proteins that Interact With VimA 
PG2096, designated regT (regulator of gingipain activity at elevated 
temperatures) was determined by in silico analysis to have 62% homology with the gene 
for Sgp G protein from Streptococcus mutants; additionally it had several RNA binding 
sites but no DNA binding sites. The isogenic regT mutant (FLL205) showed increased 
autolysis when compared to the parent strain when grown at 42C up to 24 hours though 
there was no significant difference in the growth rate; however, when grown under 
oxidative stress, the regT defective mutant was more resistant to hydrogen peroxide 
than the wild-type.  Gingipain activity of FLL205 was demonstrated to be dependent on 
the temperature at which it was grown. At 37C, gingipain activity was lower than the 
wild-type, while at elevated temperature, gingipain activity was increased when 
compared to the wild-type. Though there was no change in the expression level of 
gingipain genes in (127) the wild-type compared with the mutant, immunoblot analysis 
showed that the catalytic domain of the Arg-X from cells grown at 42C was more stable 
in the FLL205 than the wild-type. These results indicate that RegT facilitates the normal 
maturation/processing of gingipains at normal temperature at the posttranscriptional 
level (140) 
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HtrA in several organisms has been shown to be involved in protein folding and 
maturation in addition to degradation of misfolded proteins (58,68). Inactivation of this 
gene in P. gingivalis (FLL203) resulted in a phenotype that was similar to the wild-type, 
i.e. was black-pigmented and -hemolytic. This mutant strain was more sensitive to 
oxidative stress when compared to the wild-type, and this sensitivity was most 
pronounced during the stationary growth phase. FLL203 also grew at a slower rate at 
37C, but grew more slowly at 42C when compared to the wild-type; additionally, its 
growth did not exceed OD600 of 0.9. There was no significant difference in the Arg-X 
activity between the mutant and wild-type strain at 37C; however, after heat treatment, 
wild-type Arg-X activity increased by 7% while Arg-X activity decreased by 13% relative 
to an untreated control.  No Arg-X immunoreactive bands were observed in the htrA-
defective mutant. These results point to a role for HtrA in gingipain regulation at elevated 
temperatures (117). 
 
DNA Damage and Repair 
 The repair activity of a mutagenic 8-oxoG lesion in P. gingivalis is dissimilar 
from E. coli, as enzymatic removal o f8-oxo-G occurs by DNA cleavage several bases 
away from the lesion. Greater 8-oxoG repair activity was observed in FLL92 compared 
with the wild-type. The cleavage pattern for 8-oxoG lesions was also demonstrated to be 
independent of the position of the 8-oxoG within the fragment (66,67). In comparison to 
other oral anaerobes, only P. gingivalis demonstrated a different pattern for the 
enzymatic removal of 8-oxoG, suggesting that this repair mechanism might be unique to 
P. gingivalis. Though our lab previously speculated that the repair mechanism for the  8-
oxo-G lesion could a nucleotide excision repair like mechanism, further studies have 
indicated that this is not the case. The uvrB defective mutant from P. gingivalis was more 
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sensitive to UV irradiation that the wild-type strain and there was no difference in 
sensitivity to oxidative stress in the uvrB-defective mutant compared to the wild-type. 
Additionally, repair of oxidative stress-induced DNA damage was similar for both the 
wild-type and the uvrB defective mutant; this rules out uvrB-dependent nucleotide 
excision repair as a means of repairing 8-oxo-G lesions. Several lesion specific binding 
proteins were observed to bind the oligonucleotide carrying the 8-oxo-G, including 
PG10376. These proteins are suggested to form part of a unique mechanism for the 
removal and repair of 8-oxo-G lesions (52). 
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Fig. 1.9. rVimA interacts with gingipains RgpA, RgpB and Kgp. (a) Eluates from 
interaction studies with cell lysates of P. gingivalis W83 and FLL92 in the exponential 
phase (E) or stationary phase (S) were separated by SDS-PAGE and stained with 
SimplyBlue Safestain. (b–c) Eluates from protein interactions with lysates prepared 
from cells grown to late exponential phase were analysed by immunoblotting using 
gingipain-specific antibodies: anti-RgpA (b), anti-Kgp (c) or anti-RgpB (d). W83 (–), P. 
gingivalis W83 incubated with beads only; FLL92 (–), P. gingivalis FLL92 incubated 
with beads only (negative controls) (144). 
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Table 1.2. Proteins that interact with recombinant VimA 
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Elucidating the Role and Function of the VimA 
We have previously shown that inactivation of the vimA gene which is part of the 
bcp-recA-vimA-vimE-vimF-aroG operon, alters glycosylation in P. gingivalis and plays an 
important role in protease activation in this organism. Furthermore, the gingipain RgpB 
proenzyme was secreted in the vimA-defective mutant, whereas both RgpA and Kgp 
was missing from the cell membrane (105,143). Protein-protein interaction studies using 
the 39 kDa recombinant VimA protein demonstrated interaction with the gingipains. In 
addition, other proteins known to be associated with carbohydrate metabolism and 
protease maturation also interacted with the rVimA protein (144). Collectively, these data 
suggest that VimA may be part of a protein complex that is involved in gingipain 
biogenesis/glycosylation, or may modulate other proteins that can directly/indirectly 
affect this process or cell surface structures. There is a gap in our understanding of the 
effects of VimA on cell surface structures; therefore, we will explore the hypothesis that 
the VimA of Porphyromonas gingivalis plays an important role in cell surface biogenesis. 
The following specific aims will be used to address the aforementioned hypothesis: 
 
Specific Aim One: Identification of Membrane and Extracellular 
Proteins Affected by the VimA Mutation 
Our lab has previously shown that VimA is involved in several membrane related 
processes, including: gingipain maturation, LPS biosynthesis, and carbohydrate 
biosynthesis. SDS PAGE analysis of membrane and extracellular proteins of FLL92 
versus the wild-type reveals a differential protein profile, this leads us to hypothesize that 
the vimA mutation is affecting the maturation and anchorage of several proteins. We will 
explore this hypothesis through mass spectrometric analysis and in silico analysis of 
membrane and extracellular proteins. 
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Specific Aim 2: Functional Characterization of vimA’s Involvement in 
Surface Biogenesis 
The auto aggregation phenotype observed in the vimA mutant in addition to its 
differential carbohydrate profile points to a likely role in capsular formation, fimbrial 
expression and post translational modification of proteins. Using a combination of 
electron microscopy, lectin binding assays and bioinformatics, we aim to determine the 
involvement of VimA on surface related macro structures 
 
Specific Aim 3: Exploring VimA’s Role as a Possible Acyl CoA N-acyl 
Transferase 
VimA is predicted by In silico analysis to belong to the Acyl-CoA N-acyl 
transferase; additionally, its predicted tertiary structure is similar to the FemXAB family of 
proteins which have been demonstrated to be involved in peptidoglycan formation. In 
this specific aim we will elucidate the possible role of vimA as a putative acyl transferase 
by 3H labeled palmitic acid assays, antibiotic sensitivity assays, isolation and 
characterization of the peptidoglycan and determination of chemical structure variability.  
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Summary 
The Porphyromonas gingivalis vimA gene has been previously shown to play a 
significant role in the biogenesis of gingipains. Further, in P. gingivalis FLL92, a vimA 
defective mutant, there was increased auto-aggregation, suggesting alteration in 
membrane surface proteins. In order to determine the role of the VimA protein in cell 
surface biogenesis, the surface morphology of P. gingivalis FLL92 was further 
characterized. Transmission electron microscopy demonstrated abundant fimbrial 
appendages and a less well defined and irregular capsule in FLL92 compared to the 
wild-type.  In addition, Atomic Force microscopy showed a smoother surface for the wild-
type strain in contrast to the FLL92.   Western blot analysis using anti-FimA antibodies 
showed a 41 kDa immunoreactive protein band in P. gingivalis FLL92 which was missing 
in the wild-type P. gingivalis W83 strain. There was increased sensitivity to Globomycin 
and Vancomycin in FLL92 compared to the wild-type. Outer membrane fractions from 
FLL92 had a modified lectin binding profile.  Furthermore, in contrast to the wild-type 
strain, 9 proteins were missing from the outer membrane fraction of FLL92, while 20 
proteins present in that fraction from FLL92 were missing in the W83 strain. Taken 
together, these results suggest that the VimA protein affects capsular synthesis, fimbrial 
phenotypic expression and plays a role in the glycosylation and anchorage of several 
surface proteins.  
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Introduction  
A variety of bacterial cell surface components including: capsule, 
polysaccharides, proteases (gingipains), hemmaglutinin, lipopolysacharides, major outer 
membrane proteins and fimbriae contribute to the virulence of Porphyromonas gingivalis 
[reviewed in (35,85)].  This organism, a black-pigmented, Gram-negative anaerobe, is an 
important etiologic agent of periodontal disease and is associated with other systemic 
illnesses including cardiovascular disease (10,12,17,47). Cell surface components like 
the fimbriae (3,45,83), lectin-like adhesins (9) and gingipains (42,57,60) are integrally 
involved in the adhesion, invasion and colonization of periodontal tissue. In addition, the 
gingipains are involved in several cellular processes (33) including: growth, inactivation 
of cytokines and their receptors, platelet aggregation, attenuation of neutrophil 
antibacterial activities, increasing vascular permeability and apoptosis of gingival 
epithelial cells (73). Gingipains consist of a Lysine specific protease (Kgp) and an 
Arginine specific protease (Rgp) – which is further subdivided into RgpA and RgpB; 
these cleave proteins after arginine residues, and are encoded by the rgpA and rgpB 
genes respectively. The mature form of RgpA contains a catalytic domain and a 
hemagglutin domain while RgpB possesses only a catalytic domain. Lysine specific 
protease (KGP) (28,44,58) – cleave proteins after lysine residues.  
Post-translational modifications of surface components like the gingipains, 
fimbriae and LPS play a key functional role in regulating the virulence of the organism. 
The maturation pathway of the gingipains are linked to the biosynthesis of surface 
carbohydrates (56,70) and several other proteins including the PorR (70), PorT (49,67), 
Sov (67) and VimA (77,79,80). Arg-X also play a role in processing fimbriae protein 
precursors serving as a proteinase for fimbrillin maturation (30,48). The LPS of P. 
gingivalis which has been recently shown to contain two macromolecules: O-LPS (O 
antigen attached to a lipid A core) and A-LPS (phosphorylated branched mannan 
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repeating unit attached to a lipid A core), undergo several stages of assembly including 
catalysis by a relaxed-specificity ligase which is able to attach either a branched 
phosphorylated mannan or a tetrasaccharide repeating unit to the Lipid A core (63). Lipid 
A is also present in several structural forms (32) and is likely a function of strain 
differences as well as environmental cues. 
The P. gingivalis vimA gene which is part of the recA operon and codes for a 39 
kDa protein (putative Acyl CoA N-acyltransferase) has been previously shown to be part 
of the maturation pathway for gingipains (1,80). Though the mechanism for gingipain 
regulation has not been thoroughly elucidated, we have demonstrated that vimA 
modulates the phenotypic expression of the gingipains. Additionally, inactivation of this 
gene resulted in a non-black pigmented strain designated P. gingivalis FLL92, which 
showed reduced levels of proteolytic, hemagglutinating and hemolytic activities (1,53). 
Using a mouse model, the virulence of P. gingivalis FLL92 was shown to be drastically 
reduced when compared to wild- type W83 strain. The reduced proteolytic activity 
observed in this vimA-defective mutant is as a result of a defect in the post-translational 
regulation of these genes. This is further supported by the presence of the proenzyme 
form of the gingipains in addition to their unaltered transcription in the vimA-defective 
mutant (53). There is also a late onset of gingipain activity in FLL92 which is mostly 
soluble with little or no cell-associated activity (53,79). Other studies have shown that the 
recombinant VimA can interact with the gingipains in addition to several proteins, 
including HtrA, β-lactamase, and sialidase which are known in other bacterial systems to 
be involved in post-translational regulation (80).  It still remains unclear whether the vimA 
gene product is part of a central mechanism that may be involved in the maturation or 
post-translational regulation of other cell surface proteins in P. gingivalis. 
In the present study, we further characterized the cell surface of the vimA-
defective mutant of P. gingivalis.  We investigated the role of VimA on capsule and 
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fimbriae formation and outer membrane protein expression.  In addition, the effect of cell 
surface changes on antibiotic resistance was also evaluated.  
 
Material and Methods 
Bacterial Strains and Growth Conditions  
P. gingivalis strains (W83, ATCC 33277 and FLL92) were grown in either Brain 
Heart Infusion (BHI) broth (Difco Laboratories) supplemented with cysteine (0.1%), 
vitamin K (0.5 μg/ml) and hemin (5 μg/ml) or in Trypticase Soy Broth containing 
menadione and hemin (TSBKH). Solid medium was prepared by supplementation with 
1.5% agar and 5% defibrinated sheep blood (Hemostat laboratories). All cultures were 
incubated at 37˚C in an anaerobic chamber (Coy Manufacturing) in 80%N2, 10% H2 and 
10% CO2.  Growth rates were determined spectrophotometrically at 600nm (optical 
density). 
 
Biofilm Formation Assay 
Biofilm formation was assayed in 96-well microtiter dishes (Lamont personal 
communication). Briefly, P. gingivalis was cultured overnight in TSBKH media. One ml of 
the overnight culture (mid-log phase) was centrifuged at 11,000 rpm for 2 minutes at 
room temperature. The pellet was collected and washed twice with 1 ml of PBS, then 
resuspended in a 1 ml mixture of TSBKH and PBS (1:2). Aliquots of the sample were 
added to each well. Plates were then incubated with a slight rotation for 24 hours in an 
anaerobic chamber, to allow for the development of biofilm. After removal of the culture 
supernatant, the plates were washed twice by immersion in distilled water then allowed 
to air dry for 1 hour. The biofilm was stained with 0.5% safranin for 15 min (100 µl per 
well), then washed twice with distilled water.  Ethanol (95%) was added to solubilize the 
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safranin which was transferred to a new microtiter dish. Biofilm formation was obtained 
by determining the absorbance with a plate reader at 490 nm (11). 
 
Analysis of P. gingivalis Strains by RT-PCR 
Total RNA was extracted from P. gingivalis at the early (O.D. 1.0) phase of the 
growth cycle, using the SV Total RNA Isolation System (Promega). RT-PCR was 
performed using primers specific for the FimA (Fwd – GGCAFAACCCGTTGTAGAAA, 
Rve – GACCAAAGAATTGCCGAAAA) and 16S ribosomal gene product (6). The 
protocol was done according to the one step RT-PCR kit (Invitrogen) with 1µg of 
template RNA in 50µl of RT-PCR mixture. RT-PCR in the absence of reverse 
transcriptase served as the negative control. 
 
Protein Electrophoresis and Blotting  
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed according to the manufacturers instructions (Invitrogen) on 10% bis-tris 
separating gel in MOPS (morpholinepropanesulfonic acid) SDS running buffer. Proteins 
on SDS-PAGE gels were electrophoretically transferred to a nitrocellulose membrane 
(Whatman Optitran BA-S 85) and the blotted membranes immunostained with polyclonal 
anti-FimA (36). Lectin studies using Agaricus bisporus [ABA; specific for Galactose (β 
1,3) N-Acetylgalactosamine], Concanavalin A [ConA; specific for α- mannose  & α- 
glucose], Dolichos biflorus [DBA; specific for N-acetyl-α-D-galactosamine], Erythrina 
cristagalli [ECA; specific for Galactose (β 1,4) N-Acetylglucosamine], Glycine Max [SBA; 
specific for N-acetyl-D-galactosamine], Limulus polyphemus [LPA; specific for Sialic Acid 
(N-Acetyl neuramic acid)] and Triticum vulgaris [WGA; specific for N-acetyl-β-D-
glucosamine], were done according to the recommendations of the manufacturer (Sigma 
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Aldrich). In brief, blots were blocked in phosphate buffered saline (PBS) containing 2% 
TWEEN for 2 minutes at 20˚C. Blots were then rinsed twice in PBS, and incubated with 
1 μg/ml of lectin-peroxidase in PBS containing 0.05% TWEEN, with 1 mM CaCl2, 1 mM 
MnCl2, and 1 mM MgCl2 for 16 hours at 20˚C. Surplus lectins were removed by rinsing 
with PBS; the blots were developed using the DAB staining kit with nickel enhancement 
(Vector Laboratories) (37).    
 
Microscopic Examination 
Atomic Force Microscopy (AFM) and transmission Electron microscopy (TEM) 
were used to provide detailed visuals of the surface morphology. AFM was done using 
W83 and FLL92 stains grown overnight to OD 1.2, washed twice in 0.1M PBS buffer pH 
7.4 and mounted on a cover slide. AFM was performed using the Innova Scanning 
Probe Microscope (Veeco Instruments Inc) in air using the tapping mode. Images were 
captured in the height mode with a resolution of 256x256 (62). Transmission Electron 
Microscopy was performed using the Philips Tecnai 12 TEM as per the method of Hyatt 
(27). Briefly, Formvar-carbon coated grids were prepared; the Formvar support was 
removed by placing the grids in an atmosphere of solvent vapor. Grids were then placed 
on a wire mesh in a glass Petri dish with carbon tetrachloride below the wire mesh. One 
µl of the serially diluted sample was placed under the carbon side of a 4x5 mm square of 
mica (approximately twice the size of an EM grid). The grid was washed in 0.5% acetic 
acid then acetone. The carbon film was broken to free the specimen grid, after which the 
grid was placed in stain solution - neutral 1% aqueous phosphotungstic acid for 30 
seconds. After blotting dry, the grid was examined using the Tecnai TEM (FEI). 
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Localization of FimA in P. gingivalis by Immunogold Straining 
Anti-FimA antibodies (36) were purified and used at a working concentration of 
1:100. The colloidal gold conjugate, 10 nm in size (Aurion), was diluted using incubation 
buffer (20mM phosphate buffer, 150 mM NaCl pH7.4, 0.2% BSA, 15mM NaN3) to 
1:1000. A checker board titration of primary antibody to immunogold conjugate was 
made to identify the optimal working concentration. Processed nickel grids were 
subjected to charging of the processed P. gingivalis strains for a period of 1 hour, then 
washed 20 times in 0.025M TRIS buffer and lightly blotted. Grids were subsequently 
blocked with 5% Bovine serum albumin in 0.025M TRIS buffer for 15 minutes at room 
temperature, then incubated in diluted antibody-gold complex for 4 hours at 37oC. 
Staining was done using uranyl acetate (0.8g of uranyl acetate dissolved in 10ml of 
absolute ethanol) and freshly prepared lead citrate (10-40mg lead citrate, 10ml of filtered 
water, 100µl of 10N NaOH). Grids were immersed in uranyl acetate for 7 minutes at 
room temperature and then washed, once by immersion in 25% ethanol and twice by 
immersion in water. Grids were dried on filter paper for 10 minutes at room temperature, 
and then floated on lead citrate drops for 5 minutes. Following two washes by immersion 
in 0.02N sodium hydroxide and drying, grids were visualized using the Philips Tecnai 12 
TEM. 
  
Hydrophobicity Assay 
Hydrophobicity assays of P. gingivalis strains were based on adhesion to 
hexadecane according to the method of Grivet (22). Bacteria were harvested during 
exponential growth phase by centrifugation at 4˚C for 15 minutes then washed with 0.1M 
PBS (pH 7) and resuspended in PBS. The optical density of the samples was adjusted 
to 0.85 at 600 nm. Three ml of bacterial suspension was placed in a polystyrene tube to 
which 400 µl of hexadecane was added. No hexadecane was added to the control 
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suspensions. Suspensions were equilibrated in a water bath at 37˚C, vortexed for two 30 
second periods with five second intervals and allowed to stand until the phases 
separated. The lower aqueous phase was carefully removed and its optical density 
determined at 600 nm. The values obtained were expressed as the percentage of 
bacteria remaining in the aqueous phase compared with the control suspension.  
 
Determination of Minimum Inhibitory Concentrations (MIC) 
Serial dilutions of antibiotics were used to determine MIC values in broth. These 
experiments were done in duplicates. In brief, broth macro dilutions of W83 and FLL92 
were carried out using tubes containing 9 ml BHI-HK broth plus 1 ml of antibiotic dilution. 
Tubes were examined for turbidity after incubation at 37ºC for 72 hours in an anaerobic 
chamber (84). The MIC was taken as the concentration at which no visible growth was 
observed.  
 
Labeling of P. gingivalis with [3H]-Palmitic Acid 
P. gingivalis cells were labeled according the protocol of Shoji (69). Briefly, 5 ml 
cultures of W83 and FLL92 were incubated for 24 hours in BHI-HK in the presence of 50 
µCi/ml of Palmitic acid [9,10(n)-3H] (MP Biomedicals). Cells were then centrifuged, 
washed in PBS buffer and homogenized using glass beads to derive total proteins. 
Protein fractions were subsequently run on an SDS-PAGE gel. Radiolabeled proteins 
were detected using autoradiography as previously reported (82). 
 
Bioinformatics Analysis of VimA 
Protein modeling of Vim A was conducted using I-Tasser (87,88). The subcellular 
location of the protein was predicted from its amino acid sequence using SignalP 3.0 
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(50), Phobius (29) and PsortB (19). Protein motifs and domains of VimA were identified 
using PPSearch (59) and Superfamily (20).  
  
Cell Fractionation 
The Sarkosyl method was used to prepare outer membrane fractions of P. 
gingivalis (61). In brief, P. gingivalis cells were harvested from a 500 ml culture during 
the exponential and stationary phase of the growth cycle (OD 0.6-1.0 and 1.5-1.8 
respectively). Cells were pelleted at 9000xg for 30 minutes at 4ºC then resuspended in 5 
ml of 20 mM Tris HCL (pH 7.4), 10 mM EDTA, 10 mM of Nα-p-tosyl-L-lysine 
chloromethyl ketone (TLCK) and 1% sodium lauryl sarcosinate. Cells were disrupted by 
passage through a French pressure cell at 109 MPa. Whole cells were removed by 
further centrifugation at 5000xg for 20 minutes at 4ºC. The outer membrane fraction was 
separated by centrifugation (100,000xg for 30 minutes), and then the pellet was washed 
three times in 0.5% sodium lauryl sarcosinate and resuspended in 20 mM Tris HCL (pH 
7.4). Extracellular fractions were prepared from cell-free culture fluid precipitated with 
60% acetone (-20ºC) (80). The protein pellet was resuspended in 7 ml 100 mM Tris-HCL 
buffer (pH 7.4) in the presence of 1 mM N-p-tosyk-L-lysine chloromethyl ketone (TLCK), 
dialyzed for 48 hours against the same buffer then stored at -20ºC. Total proteins were 
harvested from a 50 ml culture during the late exponential phase. Cells were pelleted at 
8000xg for 30 minutes then resuspended in 1 ml of 25 mM Tris HCL (pH 8.0) with a 
protease inhibitor cocktail tablet (Complete EDTA-free, Roche Indianapolis, IN), RNase 
and DNase. Resuspended cells were then transferred to a 2 ml cryogenic tube 
containing 1 g of 0.1 mm glass beads.  Cells were lysed in a Beadbeater homogenizer 
for 4 minutes with 30 second intervals with 1 minute cooling on ice. Samples were then 
centrifuged (10,000xg) for 12 minutes 4ºC. The upper aqueous layer containing the total 
protein fraction was removed and stored on ice or at -20ºC. 
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Digestion of P. gingivalis Wild-type and FLL92 Proteins 
Late exponential and stationary membrane proteins were run on a 10% bis-Tris 
gel (Invitrogen, Carlsbad, CA) in 1X MOPS running buffer for 1.5 cm, then visualized by 
staining with SimplyBlue safe stain (Invitrogen) (25). After destaining in water, the gel 
was cut into 1-2 mm slices. Gel slices were subsequently dehydrated in acetonitrile and 
dried in a vacuum centrifuge for 30 minutes. The gel slices were incubated for 1 hour at 
60ºC in  a solution containing 20 µl of 20mM Dithiothreitol in 100mM NH4HCO3 (enough 
to cover the gel pieces). The Dithiothreitol solution was replaced with an alkylating 
solution (20 µl of 200 mM iodoacetamide in 100 mM NH4HCO3) after cooling the proteins 
to room temperature. Gel slices were further incubated at ambient temperature for 30 
minutes in the dark, followed by two washes with 150 µl of 100 mM NH4HCO3, then finely 
minced with a flame sealed polypropylene pipette tip, dehydrated by the addition of 
acetonitrile, and vacuum dried. Following an overnight incubation of the gel pieces with 
20 µl digestion buffer [1 µl of mass spectrometry (MS)-grade trypsin 
(www.promega.com) in 50 mM acetic acid with 1 µl of 100 mM NH4HCO3], the digestion 
reaction was stopped with 10 µl of 5% formic acid. After transferring the digest solution 
(aqueous extraction) to a 0.65 ml siliconized tube, 30 µl of 50% acetonitrile with 0.1% 
formic acid was added, the mixture was vortexed for 3 minutes, centrifuged and then 
sonicated for 5 minutes. The process was repeated and both extractions pooled and 
concentrated to 10 µl in a vacuum centrifuge. Peptide extraction was accomplished 
using standard C18 ZipTip technology following the manufacturer’s directions (Millipore, 
Bedford, MA). 
 
MS and Data Analysis 
An LCQ Deca XP Plus system (www.thermo.com)  with nano-electrospray 
technology (www.newobjective.com) consisting of a reverse phase C18 separation of 
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peptides on a 10 cm by 75μm capillary column using Microm Magic RP-18AQ resin 
(www.michrom.com) with direct electrospray injection to analyze the extracted peptides 
from each gel piece (25). A four part protocol was used for the MS and MS/MS analyses, 
this included one full MS analysis (from 450 to 1750 m/z) followed by three MS/MS 
events using data-dependent acquisition, where the most intense ion from a given full 
MS scan was subjected to collision-induced dissociation, followed by the second and 
third most intense ions. The nanoflow buffer gradient was extended over 45 minutes in 
conjunction with the cycle repeating itself every 2 seconds, using a 0-60% acetonitrile 
gradient from buffer B (95% acetonitrile with 0.1% formic acid) developed against buffer 
A (2% acetonitrile with 0.1% formic acid) at a flow rate of 250 to 300 nl/min, with a final 5 
minute 80% bump of buffer B before re-equilibration. In order to move the 20 µl sample 
from the autosampler to the nanospray unit, flow stream splitting (1:1000) and a Scivex 
10 port automated valve (Upchurch Scientific, Oak Harbor, WA) together with a Michrom 
nanotrap column was used. The spray voltage and current were set at 2.2kV and 5.0μA, 
with a capillary voltage of 25V in positive ion mode. 160°C was used as the spray 
temperature for peptides. Data collection was achieved using the Xcalibur software 
(Thermo Electron), then screened with Bioworks 3.1. MASCOT software 
(www.matrixscience.com) was used for each analysis to produce unfiltered data and out 
files. Statistical validation of peptide and protein findings was achieved using X! 
TANDEM (www.thegmp.org) and SCAFFOLD 2 meta analysis software 
(www.proteomesoftware.com). The presence of two different peptides at a probability of 
at least 95% was required for consideration as being positively identified. Confirmation of 
individual peptide matches was achieved using the BLAST database 
(www.oralgen.lanl.gov)  
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Results 
In silico Analysis of VimA Reveals Close Similarity to the Fem Family 
of Proteins 
Using I-TASSER  the putative structure of the VimA was modeled, this structure 
has a confidence score of 0.54 (Fig. 2.1). Several binding sites were also predicted (Fig. 
2.2) the predicted structure is similar to the FemA of Staphylococcus aureus (TM-score 
0.81) and FemX of Weisella viridiscens (TM-score 0.89). The gene ontology is predicted 
to include a role in one or more of the following: peptidoglycan biosynthetic process, 
cellular component biogenesis, cell wall biogenesis, peptidoglycan based cell wall 
biogenesis, metabolic process, biosynthetic process, carbohydrate biosynthetic process, 
primary metabolic process, carbohydrate metabolic process and peptidoglycan 
metabolic process. SignalP 3.0 and PSortb predicted no signal peptide in the VimA 
sequence, suggesting that this protein is not secreted. Phobius scores the likelihood of 
VimA being a non-cytoplasmic protein at 0.83. Using EMBL protein interaction software 
v.8.1, predicts VimA to directly interact with several proteins including several 
uncharacterized putative proteins of unknown functional etiology. The cysteine 
proteases (PG0506-RgpB) are associated with VimA with a score of 0.808. The 
bacterioferritin combinatory protein (BCP) has an interaction score of 0.582 and is 
involved in storage of Iron in the form of hydrated ferric oxide. Lys1 mediates lysine 
biosynthesis through the enzyme saccharopine dehydrogenase, while RecA has multiple 
activities, all related to DNA repair. Position specific iterative protein classifier and 
Superfam 3.0 predicts VimA to belong to the DUF482/CH1444 and/or Acyl CoA N-
acyltransferase superfamily.
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A 
Fig. 2.1. (A) Model of the VimA protein (c score 0.54). (B) Predicted binding site 
residues (shown in green): Leu:55 GLY:56 SER:57, PHE:71 ARG:72 ALA:73, VAL:77 
HIS:78 MET:84, TYR:95 SER:96 LYS:97, TYR:58 SER:59, ARG:75 ARG:76, HIS:88 
PHE:91, and GLN:108 TRP:297 
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The Surface Morphology is Affected by the vimA Mutation 
Auto-aggregation in P. gingivalis seems to be correlated to the absence of a 
capsule and the presence of fimbriae (11).  Atomic force and transmission electron 
microscopy were used to visualize likely differences between the mutant and the wild-
type. Micrographs of W83 (Fig. 2.2. A) and FLL92 (Fig. 2.2. B) revealed differences in 
the capsular structure. The Capsule of W83 was solid and well defined in contrast to the 
capsule of FLL92 which was less defined and irregular. AFM micrographs of W83 (Fig. 
2.2. C) and FLL92 (Fig 2.2. D) showed FLL92 to have distinct fine structures, resulting in 
a corrugated appearance, in contrast to the smooth morphology of W83. FLL92 cells 
also tended to clump together. Immunogold staining of W83 (Fig. 2.2. E) and FLL92 (Fig. 
2.2. F) showed adherence of gold particles to abundant fimbrial appendages in FLL92 in 
contrast to few gold particles adhering in W83. 
 
Expression of Fimbrial Genes in the vimA Defective Mutant 
The autoaggregation observed in FLL92 could have been as a result of changes 
to the fimbrial protein. It is also possible that VimA may also be involved in the post 
translational regulation of fimbrial expression. To confirm the presence of the mRNA 
transcript for the FimA gene, total RNA was isolated from wild-type and FLL92 strains 
grown to stationary phase. Using reverse transcriptase with specific oligonucleotide 
primers for an intragenic region of the fimA gene, a predicted 0.6 kb fragment was 
amplified for both the wild-type and FLL92 isogenic strain. Immunoblotting of outer 
membrane and total protein fractions of FLL92 and W83 with the FimA antibody 
revealed strong immunoreactivity with a 41-43 kDa band in both fractions of FLL92 (Fig. 
2.3.). This band which corresponds with the expected size of FimA was absent in both 
fractions of W83.
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Fig. 2.2 TEM micrographs of W83 (A) and FLL92 (B) showing capsule (CP) with 
vesicles (MV). AFM micrographs of W83 (C) and FLL92 (D). Immunogold 
localization of P. gingivalis FimA in W83 (E) and FLL92 (F), visualized by TEM after 
incubation with anti FimA serum conjugated to 10-nm gold particles (GP). 
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 Marker            33277(OM)      W83 (OM         FLL92 (OM)           33277(TP)          W83 (TP)            FLL92 (TP)  
Fig. 2.3. Immunoblot analysis using anti-FimA antibody with outer membrane 
(OM) and total protein (TP) fractions of P. gingivalis ATCC 33277, W83 and 
FLL92. A 41kDa protein corresponding with the expected size of the FimA 
was observed in the vimA mutant. 
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There is no Change in the Hydrophobicity or Ability to Form Biofilm in 
FLL92 
Adhesion to hexadecane was used to determine the hydrophobicity of W83 and 
FLL92; ATCC 33277 served as a control (known to form biofilm and auto-aggregates). 
There was no change in the hydrophobicity profile of FLL92 compared to W83. 55% of 
ATCC 33277 cells adhered to hexadecane, this is reflective of their hydrophilic surface 
properties. The ability of the vimA defective mutant FLL92 to form biofilm as quantified 
by adherence to the surface of 96 well plates was unchanged when compared to the 
W83 (data not shown). 
 
Bacterial Cell Surface/Membrane Modifications Can Alter 
Antimicrobial Sensitivity 
Several antibiotics with varying targets were employed in antibiotic sensitivity 
testing of FLL92. FLL92 showed increased sensitivity to Globomycin (10 µg/ml 
compared with 25 µg/ml in W83) and Vancomycin (5µg/ml compared with 10 µg/ml in 
W83) 
  
The VimA Affects Outer Membrane Proteins Glycosylated with 
Specific Carbohydrate Moieties 
Previous reports from our laboratory have documented the changes in the 
glycosylation profile of FLL92 compared to wild-type W83 (79). To further confirm the 
role of VimA in post translational glycosylation of outer membrane proteins, lectins were 
used. Differential lectin bound protein profiles were observed using ConA, DBA, ECA, 
LPA and SBA (Fig. 2.4.). No discernable differences were observed using WGA or ABA.   
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VimA Affects the Anchorage of Several Membrane Bound Proteins 
Mass Spectrometric analysis of membrane fractions of W83 and FLL92 identified 
20 proteins that were absent from the wild-type membrane fraction but present in the 
FLL92 fraction (Table 2.1.). While 13 of these proteins are hypothetical, PG0083, 
PG0581, PG0602, PG0703 and PG1496 are predicted to be involved in transport 
(http://www.oralgen.lanl.gov/). Nine proteins were identified as missing from the FLL92 
fraction in contrast to the wild-type (Table 2.2.). These included three proteases: RgpA 
(PG1768), Kgp (PG1605) and Carboxypeptidase D (PG0212) in addition to PG0554 and 
PG1136 which are predicted to be involved in amino acid biosynthesis 
(http://www.oralgen.lanl.gov/). PG1857 which is predicted for involvement in glycolysis or 
gluconeogenesis (http://www.oralgen.lanl.gov/) was also identified as missing. Twenty 
one membrane proteins were identified as having variable spectral counts (Table 2.3.), 
corresponding with a fold change of 1.4 or greater. Ten of these proteins showed a 
positive fold change in the VimA mutant while 11 showed a negative fold change. The 
majority of these proteins were predicted to be involved in cell envelope biogenesis or 
transport (http://www.oralgen.lanl.gov/). 
 
Analysis of Missing Membrane Proteins Reveals Several Common 
Motifs 
Using PPSearch (http://www.ebi.ac.uk/Tools/ppsearch/), several common 
domains were identified in the missing proteins identified by MS analysis (Table 2.4.). In 
PG1768 (RgpA), PG1605 (Kgp), PG0212 (Carboxypeptidase D) and PG0981 
(Hypothetical) the most abundant motifs were myristoylation sites (13, 11, 49 & 37 
respectively), Casein Kinase II phosphorylation motifs (19, 14, 29 & 35 respectively) and 
Protein Kinase C motifs (15, 16, 27 & 20 respectively). 
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191kDa  
 
 
 
64Kda - 
 
51KDa - 
 
 
39KDa - 
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19KDa -  
 
 
ABA ConA DBA ECA 
W83            FLL92 W83            FLL92 W83            FLL92 W83            FLL92
WGA
W83            FLL92W83            FLL92W83            FLL92 
LPA SBA
W83            FLL92
Brilliant Blue 
stained Gel
Fig. 2.4. Outer Membrane preparations from P. gingivalis W83 and FLL92 
were transferred to nitrocellulose, blocked in PBS then incubated with 
lectin-peroxidase overnight. Peroxidase activity was detected using the 
DAB peroxidase substrate kit. Differential lectin binding was observed 
using ConA, DBA, ECA, LPΑ and SBA.  
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Table 2.1. MS analysis of aberrantly expressed proteins in FLL92 
   
Identified Proteins Accession 
# 
Putative Role/Function M.W. W83 S.C.V FLL92 
S.C.V 
  conserved hypothetical protein (possible alkaline secretion 
  protease) 
PG0083 Transport and binding  56 kDa 0 4 
  conserved hypothetical protein; possible lipoprotein PG0219 Unknown 32 kDa 0 82 
  hypothetical protein PG0302 Unknown 47 kDa 0 7 
  conserved hypothetical protein PG0332 Unknown 22 kDa 0 1 
  hypothetical protein PG0334 Unknown 82 kDa 0 2 
  conserved hypothetical protein PG0373 Unknown 30 kDa 0 16 
  conserved hypothetical protein PG0410 Unknown 48 kDa 0 4 
  periplasmic serine protease PG0535 Proteolysis 53 kDa 0 1 
  tonB receptor tlr (C-terminal part) PG0581 Transport 44 kDa 0 4 
  heme-binding protein/peripheral outer membrane 
  chelatase 
PG0602 Transport and binding  33 kDa 0 4 
  probable biopolymer transport (tolQ) protein PG0703 Transport 29 kDa 0 3 
  hypothetical protein PG0809 Unknown 16 kDa 0 2 
  conserved hypothetical protein PG0922 Unknown 55 kDa 0 7 
  probable outer membrane lipoprotein  PG1177  Cell wall biogenesis 21 kDa 0 18 
  conserved hypothetical protein PG1308 Unknown 100 kDa 0 24 
  conserved hypothetical protein PG1496 Transport 99 kDa 0 19 
  conserved hypothetical protein PG1772 Proteolysis 98 kDa 0 4 
  hypothetical protein PG1790 Unknown 10 kDa 0 1 
  outer membrane protein (immunogenic 23 kDa 
  lipoprotein) 
PG1793 Cell wall biogenesis 23 kDa 0 44 
  probable integral outer membrane protein  PG1840 Cell wall biogenesis 24 kDa 0 24 
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Table 2.2. MS analysis of missing proteins in FLL92 
 
Identified Proteins Accession # Putative Role/Involvement M.W. W83 S.C.V FLL92 S.C.V
carboxypeptidase D / immunoreactive 92 kDa 
antigen  
PG0212 Proteolysis 92 kDa 3 0 
hypothetical protein PG0554 Cell redox homeostasis 38 kDa 95 0 
conserved hypothetical protein PG0981 Unknown 107 kDa 3 0 
branched-chain amino acid aminotransferase  PG1136 Amino acid biosynthesis 38 kDa 11 0 
peptidylarginine deiminase PG1249 Arginine & Proline metabolism 62 kDa 100 0 
porphypain polyprotein; lys-
Xproteinase/hemagglutinin 
PG1605 Proteolysis/Pathogenesis/DNA 
replication & repair 
188 kDa 60 0 
hypothetical protein PG1722.1 Unknown 24 kDa 5 0 
arginine-specific cysteine proteinase; gingipain  PG1768 Proteolysis/Pathogenesis/DNA 
replication & repair 
186 kDa 92 0 
glyceraldehyde 3-phosphate dehydrogenase PG1857 Glycolysis/gluconeogenesis 36 kDa 60 0 
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Table 2.3. MS analysis of proteins with different spectral count values in W83 and FLL92 
 
Identified Proteins Accession # Putative 
Role/Involvement 
M.W. Fold 
Change 
W83 S.C.V FLL92 
S.C.V 
  probable outer membrane lipoprotein  PG0916 Cell envelope 63 kDa 7.1 26 185 
  possible outer membrane-associated protein PG1893 Cell envelope 54 kDa 4 40 10 
  tonB-linked outer membrane receptor  PG0601 Transport & Binding 85 kDa 3.6 5 18 
  possible outer membrane-associated protein  PG1424 Cell envelope 61 kDa 3.2 17 54 
  outer membrane protein PG0626 Cell envelope 42 kDa 2.6 156 408 
  possible lipoprotein PG1600 Unknown 51 kDa 2.2 5 11 
  outer membrane protein PG0627 Cell envelope 43 kDa 2 129 256 
  probable integral outer membrane protein  PG1592 Cell envelope 24 kDa 1.9 29 56 
  probable integral outer membrane protein  PG1562 Cell envelope 32 kDa 1.6 11 17 
  tonB-dependent outer membrane receptor PG0170 Transport 112 kDa 1.5 452 674 
  receptor antigen B PG0171 Cell envelope 56 kDa -1.4 455 316 
  tonB-linked receptor Tlr PG0582 Transport 51 kDa -1.4 14 10 
  tonB-linked outer membrane receptor PG1752 Transport 93 kDa -1.5 15 10 
  hypothetical protein PG0197 Unknown 33 kDa -1.8 9 5 
  conserved hypothetical protein; possible TonB-
dependent receptor 
PG0899 Transport 100 kDa -2 8 4 
  outer membrane protein, TonB dependent receptor PG0637 Transport 94 kDa -2.9 52 18 
  phenylalanine/histidine ammonia-lyase PG0299 Histidine catabolysis  55 kDa -3.3 23 7 
  outer membrane protein PG1901 Cell envelope 32 kDa -3.6 29 8 
  beta-galactosidase PG0598 Carbohydrate 
metabolism 
127 kDa -3.8 15 4 
  hypothetical protein PG1894 Unknown 21 kDa -10.8 43 4 
  tonB-linked outer membrane receptor PG1242 Transport 96 kDa -16 80 5 
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Palmitic Acid Assay Shows VimA to Be Involved in the Acylation of 
Proteins 
Several outer membrane proteins are lipid modified in P. gingivalis (85). To 
determine whether the VimA could play a role in lipid modification of proteins P. 
gingivalis was grown in the presence of 3H labeled palmitic acid. No change in the 
acylation profile was observed in the total protein fractions of the wild-type or FLL92 
grown to exponential phase (Fig 2.5. B). In the extracellular fraction from FLL92 grown to 
exponential phase (Fig 2.5. B), a 54 kDa protein was observed in W83 which had 3 
times the intensity of that observed in FLL92; while a 27 kDa protein was observed in 
FLL92 with twice the intensity of W83 (Fig 2.5. C). 
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TABLE 2.4. Predicted motifs present in missing FLL92 membrane proteins 
 PG0212 
(Carboxy-
peptidase 
D) 
PG0554 
(Hypothetical 
Protein) 
PG0981 
(Hypothetical 
protein) 
PG1136 
(Branched 
Chain AA 
transaminase) 
PG1249 
(Peptidylarginine 
deiminase) 
PG1605 
(Kgp) 
PG1722.1 
(Hypothetical 
protein) 
PG1768 
(RgpA) 
PG1857 
(Glyceraldehyde 
3-phosphate 
dehydrogenase) 
MYR * 13 3 11 6 8 49 7 37 7 
TYR_PHOS**  0 0 2 0 0 1 0  0 0 
CK2_PHOS† 19 5 14 4 5 29 3 25 8 
PKC_PHOS†† 15 5 16 3 6 27 5 20 5 
CAMP_PHOS‡ 1 0 1 0 1 2 1 2 1 
ASN_GLYC ‡‡ 8 4 0 3 5 15 1 17 3 
Amidation § 1 0 3 0 
 
 
1 4 0 4 0 
Unique Zinc_Car¶ None  None None None DNA- 
Lig# 
None DNA-Lig GAPDH## 
(*-N-myristoylation site, **-Tyrosine kinase phosphorylation site, †-Casein kinase II phosphorylation site,  ††-Protein kinase C 
phosphorylation site, ‡-cAMP and cGMP-dependent protein kinase phosphorylation site, ‡‡-N-glycosylation site, §-Amidation site, ¶-Zinc 
Carboxypeptidase, #-ATP-dependent DNA ligase AMP-binding site. ##-Glyceraldehyde 3-phosphate dehydrogenase active site) 
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A 
TP W83        TP FLL92      EX W83     EX FLL92 
B
TP W83       TP FLL92         EX W83     EXFLL92 
Fig. 2.5. Autoradiography of total protein (TP) and extracellular fractions (EX) of 
W83 and FLL92 grown overnight in the presence of 3H palmitic acid, (A) Brilliant 
Blue stained SDS Page gel with W83 and FLL92 TP & EX fractions.  (B) 3H 
palmitic acid labeled nitrocelluloase membrane with W83 and FLL92 TP & EX 
fractions. 
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C 
D 
Fig. 2.5. (continued). (C) Densitometric analysis of 3H lipid labeled proteins of W83 & 
FLL92 total protein fraction. (D) Densitometric analyis of 3H lipid labeled proteins of 
W83 & FLL92 extracellular fraction. A 54 kDa protein (B1) was three times as abundant 
as that observed in FLL92 and the 27 kDa protein (B3) was twice as abundant in FLL92 
compared with W83 
 81 
Discussion 
 Membrane integrity is critical to the survival, adaptability and pathogenicity of 
bacteria (15,18,86). In this study, we examined the role of VimA on membrane proteins 
and structures, with a view to further elucidate its role in modulating virulence in P. 
gingivalis. The role of VimA in gingipain maturation, auto-aggregation, hemolysis, 
hemagglutination, and LPS synthesis has been alluded to in previous reports (77-80); 
however, its role in membrane biogenesis has not been explored. The unique phenotype 
of FLL92 led us to hypothesize that VimA plays a significant role in membrane 
biogenesis of P. gingivalis and is integral for anchorage and maturation of membrane 
proteins. 
In silico analysis of the VimA protein predicted a structure that showed similarity 
to the Fem family of proteins. These proteins are found in Gram positive bacteria and 
are involved in cell envelope biogenesis, particularly in peptidoglycan formation 
(7,39,72). Interestingly, this protein is not predicted for secretion or cytoplasmic 
localization, suggesting that it is likely transmembrane or periplasmic. Attempts to 
localize this protein with antibodies raised against the over-expressed protein in E. coli 
have so far proven unsuccessful. The VimA protein could be classified in the 
DUF482/CH1444 and/or Acyl CoA N-acyltransferase superfamily. The DUF482/CH1444 
is part of the PEP-CTERM system that has sortase-like function and is involved in 
bacterial exopolysaccharide biosynthesis (23). Proteins exported in this system have 
conserved C-terminal sorting signals that are recognized by a sortase in Gram positive 
bacteria (13,14,40,75,76) or an analogous system termed exosortase in Gram negative 
bacteria (66). The second predicted family (Acyl-CoA N-acyltransferase) is a broad 
family which includes: N-acetyltransferase, N-myristoyl transferase, autoinducer 
synthase, FemXAB nonribosomal peptidyltransferases, Ornithine decarboxylase 
antizyme-like, AstA-like, DUF1122, EF1021-like. The VimA protein is predicted to belong 
 82 
to the FemXAB nonribosomal peptidyltransferase subfamily. Notably, the VimA is 
predicted for interaction with the RgpB (score 0.81) in addition to several other proteins. 
This is consistent with  previous reports which demonstrate that the VimA is able to 
interact with RgpB. Interestingly, several proteins including those coded for upstream 
and downstream of the vimA are predicted for interaction, it is noteworthy that several 
proteins including PG1605 (Kgp), PG0010 (β-lactamase), PG1101 (Alanyl-tRNA 
synthase), PG0535 (HtrA), PG1833 (RegT), PG0324 (putative sialidase), and PG1768 
(RgpA) that have been previously shown to interact (80) were not predicted for 
interaction. This data suggests that the VimA is likely a multifunctional protein, possibly 
forming a complex with those proteins encoded at the recA locus, and may modulate 
several virulence factors in addition to being involved in the biosynthesis of membrane 
proteins and structures.  
 We have demonstrated in previous studies that compared to the wild-type, 
FLL92 autoaggregates (53). Several reports have suggested that the expression of 
fimbriae and the absence of a capsule may contribute to auto-aggregation, which in turn 
increases the organism’s ability to form biofilm (11). Visible differences were observed 
between FLL92 and W83. These differences related to capsular formation and surface 
morphology. The capsule of FLL92 was irregular and fuzzy in contrast to the solid 
defined capsule of W83. FLL92 also had a corrugated surface morphology compared to 
the smooth morphology present in W83. Abundant immunogold particles were observed 
in the appendage like structures of FLL92; however, few gold particles were 
incorporated in the few surface related appendages of W83. Interestingly, RT-PCR 
demonstrated that the fimA gene was similarly expressed in both the wild- type and 
vimA-defective isogenic mutant.  
The presence of major fimbriae in wild-type W83 was earlier disputed (52), as 
screening by immunological means such as bacterial agglutination, ouchterlony 
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immunodiffusion and western blotting were all negative; however, electron microscopy 
has been used successfully to establish that W83 is poorly fimbriated (24,74). This is in 
contrast to highly fimbriated strains such as 33277 and 381 which show positive 
immunological fimbrial results and positive visualization by electron microscopy. In P. 
gingivalis, there are six classifications of the fimA gene (I, Ib, II, III, IV and V) (4); with the 
large majority of patients carrying either type II or IV fimA; interestingly, these genotypic 
differences do no correlate with morphological differences in fimbriae (2). W83 is type IV, 
whereas 33277 and 381 are type I (52). The relationship between capsular and fimbrial 
synthesis is at present unknown in P. gingivalis, however as has been demonstrated in 
Klebsiella pneumoniae (41, 65), fimbrial function can be impeded by expression of the 
polysaccharide capsule and can be restored by inhibiting capsular synthesis. Capsular 
formation may also impede assembly of preformed fimbrial subunits on the bacterial 
surface (65). This effect in K. pneumoniae is due to direct physical interaction as 
opposed to transcriptional or translational changes; and is in keeping with our own 
observations which show that the fimA transcript is made in the wild-type and the 
mutant. Therefore, in light of the effect of the VimA mutation on capsular synthesis, 
fimbrial function and synthesis may no longer be impeded, resulting in the assembly of 
fimbriae on the surface. The presence of the fimA message coupled with undetected 
FimA via immunoblotting, may also indicate a role for vimA in protein synthesis and 
turnover. Interestingly, these alterations in membrane structure did not affect the 
organism’s ability to form biofilm. Taken together, these findings indicate a critical role 
for VimA in capsular biogenesis and a likely indirect role in fimbrial synthesis. Further 
studies are actively being pursued in our laboratory to elucidate the role of the VimA in 
synthesis and regulation of the capsule and fimbriae. 
The corrugated surface morphology of FLL92 coupled with previous reports 
which demonstrated that though there are more proteins present in the membrane 
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fraction, other proteins such as RgpA and Kgp are missing (79,80), could suggest that 
this was likely due to the aberrant anchorage and or expression of proteins on the cell 
membrane. Our findings revealed twenty proteins that were aberrantly anchored to the 
cell wall of FLL92, nine proteins that were missing and twenty one proteins which had 
variable spectral count values. These normalized spectral count values correlate to the 
relative abundance of these proteins. Of the nine missing proteins, three are involved in 
proteolysis, these included: Carboxypeptidase D (PG0212), RgpA (1768) and Kgp 
(1605). Glyceraldehyde 3-phosphate dehydrogenase –GAPDH (PG1857) and peptidyl-
arginine deiminase (PG1249) were also missing.  
RgpA and Kgp proteinases and adhesins are C terminally processed by 
Carboxypeptidase D otherwise known as carboxypeptidase CPG70. This protein shares 
C-terminal sequence similarity to cysteine proteinases indicating a common mechanism 
for cell surface attachment and secretion (8,81).  The absence of this carboxypeptidase 
on the surface of FLL92 likely explains why RgpA and Kgp are incorrectly modified and 
inactive, existing in the extracellular milieu, but not anchored to the surface. This is in 
contrast to the surface bound yet inactive RgpB.  GAPDH is a metabolic enzyme of the 
glycolytic pathway which phosphorylates glyceraldehyde-3-phosphate to generate 1,3 
biphosphoglycerate (34). GAPDH has also been shown to exist on the surface of 
bacterial pathogens; functioning as a novel virulence factor in several bacterial species, 
by binding host proteins (38,55). In Trichomonas vaginalis, this enzyme binds 
fibronectin, plasminogen and collagen (34) while in enterohemorrhagic E. coli and 
enteropathogenic E. coli it binds human plasminogen and fibrinogen (16). In Candida 
albicans this surface associated enzyme binds to laminin and fibronectin (21).  Surface 
bound GADPH of Streptococcus oralis has been shown to play a role in P. gingivalis 
colonization. The FimA of P. gingivalis is able to bind to GADPH present on the 
streptococcal surface (46), this interaction is further used to bind to human oral epithelial 
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cells (31). The function of surface bound GADPH in P. gingivalis has not been elucidated 
however we speculate that it is likely serving to bind host extracellular matrix proteins 
present within the periodontal pocket for proteolytic degradation by the gingipains. It is 
also possible that this protein may itself contain a binding receptor for other oral bacteria 
so as to allow for biofilm formation and colonization of the oral cavity. Peptidyl arginine 
deiminase (PAD) - catalyzes the deimination of the guanidino group from carboxyl-
terminal Arg residues to produce ammonia - is released by P. gingivalis with the 
progression and development of adult-onset periodontitis. PAD provides a protective 
effect to the bacterium during the acid cleansing cycles of the mouth (68) through the 
production of ammonia. The activity of PAD distributed among cells, supernatant and 
vesicles has been shown to be growth dependent. It has also been suggested that the 
interaction between PAD and Arg-X may arise from Arg-X cleaving anti-adhesive 
humoral defense peptides containing internal arginyl residues and other arginine 
carboxyl terminal defense peptides, which are then inactivated by PAD (43,64). It is 
likely that anchorage of PAD may be dependent on the carboxypeptidase D processing. 
The reported interaction between between Arg-X and PAD, leads us to hypothesize that 
the enzymatic capabilities of PAD may be compromised as Arg-X is inactive, thus 
reducing its efficacy. Further studies are needed to clarify this hypothesis. 
When missing proteins were examined for protein motifs using PPsearch - a 
protein motif identifier software, myristoylation and phosphorylation sites were in great 
abundance in all of the missing proteins. Of the 20 proteins, 13 were hypothetical 
proteins, 9 of which had an unknown function. Further, PG0535 (Serine periplasmic 
protein) which has been shown to interact with VimA is aberrantly expressed on the 
membrane of the FLL92. This study also confirmed in FLL92 the missing membrane-
associated RgpA and Kgp as previously reported (79,80). These findings likely explain 
the auto-aggregation that is observed in FLL92 and support a role for VimA in anchorage 
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and maturation of membrane proteins, possibly through myristoylation or 
phosphorylation. The specific interaction between the VimA and missing or aberrantly 
expressed proteins is being investigated. 
In the vimA defective mutant there is aberrant protein glycosylation (79).  It is not 
known however whether this aberrant glycosylation is specific to certain carbohydrate 
moieties. To clarify the effect of the vimA mutation on glycosylation of outer membrane 
proteins, lectins were used. Outer membrane proteins glycosylated with Galactose (β 
1,3) N-Acetylgalactosamine, N-acetyl-α-D-galactosamine, Galactose (β 1,4) N-
Acetylglucosamine, N-acetyl-D-galactosamine and Sialic Acid (N-Acetyl neuramic acid) 
were affected by the vimA mutation. Whether this due to the glycosylation of aberrantly 
expressed proteins (i.e. proteins that are not present on the wild-type membrane but 
present on the membrane of FLL92) or proteins that are incorrectly processed as is the 
case with RgpB is still an active area of exploration. These findings suggest that the 
VimA plays a role in the correct glycosylation of several membrane proteins. 
Since several outer membrane proteins are lipid modified in P. gingivalis (71), 
and in keeping with the likely role of the VimA protein as a possible acyl transferase, we 
incubated W83 and FLL92 with 3H labeled palmitic acid (lipid donor). The expression 
profile of lipid modified proteins in the wild-type and mutant was unchanged. This 
suggests that the VimA is either not involved in the acylation of outer membrane proteins 
or that there is a redundant mechanism of protein acylation. To this end, PG1355 
(putative acyltransferase) was upregulated (3.5 fold change) in FLL92 (microarray data – 
unpublished) compared to the mutant. Interestingly, densitometric analysis of the 
extracellular fractions of W83 and FLL92 for lipid modified proteins revealed a 54 kDa 
protein that was 3 times more abundant in W83 than was observed in FLL92. We also 
observed a 27 kDa protein that was twice as abundant in FLL92 as present in W83. The 
above findings may indicate a likely role for VimA in the proper acylation of a 54 kDa 
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extracellular protein; however, we have not ruled out the possibility that this protein is a 
dimer of the 27 kDa protein observed in the extracellular fraction of FLL92. Several 
reports have demonstrated that acylation is important for protein folding, protein-protein 
interaction as well as ligand induced conformational changes (5,26,54). It is possible that 
correct acylation of the 27kDa extracellular protein leads to dimerization. In the vimA 
mutant, aberrant acylation of the 27 kDa extracellular protein may occur, resulting in 
higher levels of monomeric protein form. Further studies in our laboratory are seeking to 
clarify this position. 
The expression of additional proteins attributed to membrane biosynthesis and 
transport in the VimA mutant suggest that several post translational modification 
pathways may be affected by this protein. These modifications could include 
myristoylation and glycosylation. Co-translational modifications of proteins could be 
attributed to their involvement in signal transduction pathways as molecular switches 
associated with glycine rich protein motifs. Myristoylation of proteins are reported to be 
involved in Type III secretory system in prokaryotes (51) 
The missing and aberrantly expressed proteins in FLL92 suggest that VimA 
could have sorting/transport functions. VimA could also function as an acyl CoA N-
acyltransferase enzyme involved with protein modification/anchor age of membrane 
proteins. In conclusion, our results highlight a putative central role for the VimA protein in 
protein modification and transport, possibly triggering cascade reactions that may 
modulate the virulence potential of P. gingivalis. The putative multiple functions of the 
VimA protein needs further clarification.  
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Summary 
 
Several outer membrane structures and secreted proteins contribute to the 
invasive  potential and virulence of P. gingivalis. We have previously demonstrated that 
the VimA protein of Porphyromonas gingivalis is a multifunctional protein involved in 
several cellular processes, including gingipain maturation, fimbrial synthesis, lipid 
polysaccharide polymerization and anchorage of outer-membrane proteins. In silico 
analysis predicts the VimA protein is part of the FemXAB non-ribosomal 
peptidyltransferase family which is involved in peptidoglycan synthesis. To further 
characterize the VimA, we evaluated its role in peptidoglycan biogenesis and protein 
sorting. The peptidoglycan of the vimA mutant and wild-type W83 were isolated and 
purified from cells grown to log and stationary growth phase and examined using Atomic 
force microscopy and transmission electron microscopy. Hydrolytic enzymes assays 
were used to determine differences in the rate of hydrolysis between strains. Mass 
Spectrometry was used to identify aberrantly expressed and missing extra-cellular 
proteins. Our results indicated structural and compositional differences in the 
peptidoglycan of W83 when compared to FLL92. The rate of hydrolysis with lysostaphin 
was higher in W83 than in FLL92. Notably, sixty-eight proteins were present only in the 
extracellular fraction of FLL92.  In the same fraction, there were 16 proteins present both 
in the wild-type and mutant; however, they varied in abundance. These observations 
suggest that the VimA protein is likely involved in peptidoglycan synthesis, and 
corroborates our previous report, which suggests a role for VimA in protein sorting. 
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Introduction 
Porphyromonas gingivalis is a black pigmented, Gram negative, asaccharolytic, 
anaerobic, coccobacilli, which is an important etiologic agent of periodontal disease 
(6,8,11,31). Strains from P. gingivalis are classified as either invasive or non-invasive. 
Invasive strains have been shown to possess more pathogenic activity in vivo and in 
vitro than the non-invasive strains (9,12,20,22). Furthermore, a variety of bacterial cell 
surface components including: capsule, polysaccharides, proteases (gingipains), 
hemagglutinin, lipopolysacharides, major outer membrane proteins and fimbriae 
contribute to cell adherence and virulence of P. gingivalis (26,41,43). These bacterial 
surface components may also play a role in resisting phagocytosis by leukocytes (29). 
Peptidoglycan, a constituent of the bacterial cell membrane, has been 
demonstrated to induce several host inflammatory responses.  This heteropolymer is 
comprised of glycan strands cross-linked through peptide chains. These chains are of 
two types – stem peptides that are linked to the glycan chain, and a cross-bridge that 
links stem peptides. There is significant diversity in the composition and sequence of the 
cross-bridges and stem peptides across bacterial species (5) 
P. gingivalis contains a 51kDa murC gene, which is a homologue of the E. coli 
peptidoglycan synthesis gene, and catalyses the first step in the biosynthesis of the cell 
wall peptidoglycan (2). An examination of eighteen vesicle preparations from P. 
gingivalis identified muramic acid as present in each preparation. These muramic acid 
moieties were regarded as low molecular mass compounds, as they were soluble in 
TCA [cross-linked peptidoglycans and muramic acid is reported to be insoluble in TCA]. 
This led the authors to suggest that the products of cell wall turnover – removal of 
peptidoglycan fragments from pre-existing cell wall (10), exert turgor on the outer 
membrane, which results in the herniation and blebbing of the outer membrane (44) – 
formation of vesicles. Several alternate peptidoglycan derived models of vesicle 
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formation have also been proposed (7,24). The inflammatory reaction produced in the 
host to vesicles may result in part from the presence of muramyl peptides and 
lipopolysacharides (44). 
The human proteins  (Nucleotide-binding Oligomerization Domain) Nod1 and 
Nod2 – involved in the intracellular recognition of bacterial products - though initially 
thought to recognize bacterial lipopolysacharides, is now believed to specifically 
recognize peptidoglycans. Whereas Nod1 recognizes gamma-D-glutamyl-meso-DAP 
(found primarily in gram negatives), Nod2 recognizes muramyl dipeptides (MDP) 
(14).Two common gene polymorphisms of CARD15 - encodes the Nod2 protein – in 
periodontitis patients did not reveal statistical differences between the control group and 
the periodontitis group, suggesting no role for these mutations in adult periodontitis (25). 
Furthermore, in human embryonic kidney cells stimulated with heat killed P. gingivalis, 
weak NOD1 and NOD2 stimulatory activity was observed when compared with other oral 
bacteria, suggesting that weak NOD stimulation might be important for the survival of P. 
gingivalis in the periodontal pocket (32).  Peptidoglycan from P. gingivalis has however 
been demonstrated to induce upregulation of CD14 and CD16 in dendritic cells (DCs) 
via TLR2 signaling (21). These DCs release higher levels of IL-8 and RANTES at lower 
doses than DCs stimulated with fimbriae. Peptidoglycan from P. gingivalis has also been 
shown to elicit the production of IL-6 from mouse peritoneal macrophages, and induces 
cell death in silkworm tissues via reactive oxygen species (ROS) production (19).  
In our previous studies using In silico analysis, the predicted structure of VimA 
was similar to the Fem family of proteins (33). These proteins are found in Gram positive 
bacteria and are involved in cell envelope biogenesis, particularly in peptidoglycan 
formation (4,27,38).  Several superfamily prediction software also classified this protein 
as belonging to the DUF482/CH1444 (contain determinants for C terminal sorting of 
proteins) and Acyl-CoA N-acyltransferase superfamily (broad family which includes the 
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FemXAB nonribosomal peptidyltransferases). VimA also interacts with PG1101 (Alanyl-
tRNA synthase) (40), which is likely involved in peptidoglycan synthesis. These studies 
led us to speculate that VimA is a possible acyl transferase involved directly in 
peptidoglycan biogenesis. To confirm this hypothesis, we examined the morphology of 
the peptidoglycan from W83 and FLL92, and utilized several enzymatic assays to 
elucidate the possible changes in the peptidoglycan. Mass spectrometry was used to 
determine whether the abnormal secretion protein profile observed in FLL92 was limited 
to the outer membrane proteins. 
 
Materials and Methods 
Bacterial Strains and Growth Conditions  
P. gingivalis strains (W83, ATCC 33277 and FLL92) and Enterococcus faecalis 
were grown in either Brain Heart Infusion (BHI) broth (Difco Laboratories) supplemented 
with cysteine (0.1%), vitamin K (0.5 μg/ml) and hemin (5 μg/ml) (BHIKH) or in Trypticase 
Soy Broth containing menadione and hemin (TSBKH). Solid medium was prepared by 
supplementation with 1.5% agar and 5% defibrinated sheep blood (Hemostat 
laboratories). All cultures, unless otherwise stated, were incubated at 37˚C in an 
anaerobic chamber (Coy Manufacturing) in 80%N2, 10% H2 and 10% CO2.  Growth rates 
were determined spectrophotometrically at 600nm (optical density). 
 
Complementation of vimA 
PCR mediated gene replacement was used to complement the vimA defect. In 
brief, the ORF of vimA was amplified using primers specific for the vimA. The amplified 
fragment was purified by agarose gel electrophoresis, then electroporated into electro 
competent FLL92 cells grown to log phase (OD600 of 0.6). Electroporated cells will be 
incubated for 12 hours in 1ml of broth then plated on BHIHK-blood plates. Plates were 
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then screened after 8 days for black-pigmented colonies. These colonies were 
subsequently evaluated for the presence of the uninterrupted vimA gene using PCR. 
 
Peptidoglycan Isolation from W83 and FLL92  
P. gingivalis peptidoglycan was prepared using the modified method previously 
reported by Isahii (19). In brief, 200ml of P. gingivalis W83 and FLL92 cultures were 
centrifuged (9000xg, 10mins at 10C), and the precipitates resuspended in water.  
Trichloroacetic acid (10%) was added to the sample and the mixture was incubated at 4º 
for 1 hour. The sample was centrifuged (9000xg, 5 min, 10ºC) then washed three times 
in water. The precipitate was incubated at 100ºC for 1 hour after being suspended in 
50mM sodium acetate buffer (pH 5.3) containing 8% SDS. This was followed by an 
overnight incubation at room temperature. After centrifugation (43,000xg, 1 hour, 12ºC), 
the sample was washed three times in water and resuspended in Tris HCL containing 
2% SDS and proteinase K (50µg/ml) at 37C for 12 hours.  
 
Preparation of Murein Sacculi  
Murein Sacculi was prepared from FLL92 and W83 using the method of Yao 
(42). Briefly, cells were grown to OD600 of 0.7 representing log phase  and 1.5-1.6 
representing stationary phase in 2000mls of BHIKH media. Cultures were then 
centrifuged at 6000xg for 30 minutes, washed twice  then resuspended in phosphate 
buffered saline (pH 7.0) containing 1mM magnesium chloride, then washed twice. The 
suspension was then boiled in 2% wt/vol SDS for 3 hours and left overnight at room 
temperature for 48 hours, after which it was centrifuged for 1 hour at 150,000xg (25ºC) 
to pellet the Sacculi. Sacculi were washed three times in deionized water at room 
temperature, then dialyzed overnight in one liter of deionized water.  
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Lytic Enzyme Assays 
Several peptidoglycan hydrolytic enzymes, including muramidase (Sigma), and 
lysostaphin (Sigma) were used to determine the susceptibility of peptidoglycan and the 
murein sacculi to hydrolysis. In brief, peptidoglycan was suspended in 0.1 M potassium 
hydrogen phosphate, pH 7.3 to an approximate absorbance of 0.7 at 580 nm, in a 1cm 
light path. One hundred µg/ml was added to the peptidoglycan suspension at zero time 
and incubated at 37ºC. The absorbance at 580nm was followed for 24 hour and the 
percent hydrolysis was calculated employing the absorbance of an untreated, 
peptidoglycan control (3). 
 
Microscopic Examination   
Atomic Force Microscopy (AFM) and transmission Electron microscopy (TEM) 
were used to provide detailed visuals of the morphology of the murein sacculi. AFM was 
done using treated and untreated murein sacculi, isolated from W83 and FLL92 stains 
grown to stationary (OD 1.5-1.8) and exponential (OD 0.6 – 0.7) growth phase. Samples 
were washed twice in 0.1M PBS buffer pH 7.4 and mounted on a cover slide, then 
allowed to air dry. AFM was performed using the Innova Scanning Probe Microscope 
(Veeco Instruments Inc) in air using the tapping mode. Images were captured in the 
height mode or peak force error (35). Transmission Electron Microscopy was performed 
using the Philips Tecnai 12 TEM as per the method of Hyatt (18). Briefly, sacculi were 
absorbed to 400- mesh carbon and Formvar coated EM grids. A drop of 2% (wt/vol) 
uranyl acetate was used to float the grid for 15s to negatively stain the sample, this was 
followed by microscopy using a Philips Tecnai 12 operated under standard conditions 
with the cold trap in place (42). 
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Bioinformatics Analysis of VimA  
ClustalW (ebi) was used to compare the VimA protein and gene sequences to 
the FemA, FemB and FemX, while CLC Main Workbench 5 was used to align the 
sequence of the missing extracellular proteins derived from Mass spectrometry. 
  
Cell Fractionation  
Extracellular fractions were prepared from cell-free culture fluid precipitated with 
60% acetone (-20ºC) (40) from W83 and FLL92. The protein pellet was resuspended in 
7 ml 100 mM Tris-HCL buffer (pH 7.4) in the presence of 1 mM N-p-tosyk-L-lysine 
chloromethyl ketone (TLCK), dialyzed for 48 hours against the same buffer then stored 
at -20ºC until used.  
 
Digestion of P. gingivalis Wild-type and FLL92 Proteins 
Extracellular proteins were run on a 10% bis-Tris gel (Invitrogen, Carlsbad, CA) 
in 1X MOPS running buffer for 1.5 cm, then visualized by staining with SimplyBlue safe 
stain (Invitrogen) (16). After destaining in water, the gel was cut into 1-2 mm slices. Gel 
slices were subsequently dehydrated in acetonitrile and dried in a vacuum centrifuge for 
30 minutes. The gel slices were incubated for 1 hour at 60ºC in  a solution containing 20 
µl of 20mM Dithiothreitol in 100mM NH4HCO3 (enough to cover the gel pieces). The 
Dithiothreitol solution was replaced with an alkylating solution (20 µl of 200 mM 
iodoacetamide in 100 mM NH4HCO3) after cooling the proteins to room temperature. Gel 
slices were further incubated at ambient temperature for 30 minutes in the dark, followed 
by two washes with 150 µl of 100 mM NH4HCO3, then finely minced with a flame sealed 
polypropylene pipette tip, dehydrated by the addition of acetonitrile, and vacuum dried. 
Following an overnight incubation of the gel pieces with 20 µl digestion buffer [1 µl of 
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mass spectrometry (MS)-grade trypsin (www.promega.com) in 50 mM acetic acid with 1 
µl of 100 mM NH4HCO3], the digestion reaction was stopped with 10 µl of 5% formic 
acid. After transferring the digest solution (aqueous extraction) to a 0.65 ml siliconized 
tube, 30 µl of 50% acetonitrile with 0.1% formic acid was added, the mixture was 
vortexed for 3 minutes, centrifuged and then sonicated for 5 minutes. The process was 
repeated and both extractions pooled and concentrated to 10 µl in a vacuum centrifuge. 
Peptide extraction was accomplished using standard C18 ZipTip technology following the 
manufacturer’s directions (Millipore, Bedford, MA). 
 
MS and Data Analysis 
An LCQ Deca XP Plus system (www.thermo.com) with nano-electrospray 
technology (www.newobjective.com) consisting of a reverse phase C18 separation of 
peptides on a 10 cm by 75μm capillary column using Microm Magic RP-18AQ resin 
(www.michrom.com) with direct electrospray injection to analyze the extracted peptides 
from each gel piece (16). A four part protocol was used for the MS and MS/MS analyses, 
this included one full MS analysis (from 450 to 1750 m/z) followed by three MS/MS 
events using data-dependent acquisition, where the most intense ion from a given full 
MS scan was subjected to collision-induced dissociation, followed by the second and 
third most intense ions. The nanoflow buffer gradient was extended over 45 minutes in 
conjunction with the cycle repeating itself every 2 seconds, using a 0-60% acetonitrile 
gradient from buffer B (95% acetonitrile with 0.1% formic acid) developed against buffer 
A (2% acetonitrile with 0.1% formic acid) at a flow rate of 250 to 300 nl/min, with a final 5 
minute 80% bump of buffer B before re-equilibration. In order to move the 20 µl sample 
from the autosampler to the nanospray unit, flow stream splitting (1:1000) and a Scivex 
10 port automated valve (Upchurch Scientific, Oak Harbor, WA) together with a Michrom 
nanotrap column was used. The spray voltage and current were set at 2.2kV and 5.0μA, 
 106 
with a capillary voltage of 25V in positive ion mode. 160°C was used as the spray 
temperature for peptides. Data collection was achieved using the Xcalibur software 
(Thermo Electron), then screened with Bioworks 3.1. MASCOT software 
(www.matrixscience.com) was used for each analysis to produce unfiltered data and out 
files. Statistical validation of peptide and protein findings was achieved using X! 
TANDEM (www.thegmp.org) and SCAFFOLD 2 meta analysis software 
(www.proteomesoftware.com). The presence of two different peptides at a probability of 
at least 95% was required for consideration as being positively identified. Confirmation of 
individual peptide matches was achieved using the BLAST database 
(www.oralgen.lanl.gov)  
 
Results 
VimA is Closely Related to the FemX of Weisella viridescens  
The phylogeny suggests that VimA (0.52) is closer in relation to FemX (0.45) 
than FemB (0.32) and FemA (0.29) (FemA).  Additionally, several consensus sequences 
were identified in both VimA and FemX, these included1: RY*E**RO, KL****RDG****S, 
and EG*LL (Fig. 3.2.). 
 
VimA Affects the Secretion of Several Extracellular Proteins 
Mass spectrometric analysis was done to determine whether the differential 
protein profile observed previously in FLL92 (33), was unique to the membrane proteins 
or whether this mutation also affected the extracellular protein fraction. Mass 
Spectrometry of membrane fractions of W83 and FLL92 identified 15 proteins that were 
present in the extracellular fraction but absent in W83 (Table 3.1.) and 68 proteins that 
were present in the extracellular fraction of FLL92 (Table 3.2.) but absent in W83. The 
majority of aberrantly expressed proteins were predicted for involvement in energy 
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metabolism, while the remainder was predicted to be involved in proteolysis, protein 
binding and transport, DNA metabolism or were hypothetical. Of the fifteen proteins 
identified as missing, six were predicted to play a role in cell envelope biogenesis; while 
two - PG0468 and PG1357 were predicted to be involvement in protein targeting and 
transport. Six of these proteins were hypothetical.  Seven extracellular proteins were 
identified in FLL92 as having spectral count values with negative fold changes (fc) of 1.2 
or greater (Fig 3.3.) - RgpA (PG1768, fc 1.2), Kgp (PG1605, fc 6.6), Carboxypeptidase D 
(PG0212, fc 28), Peptidylarginine deiminase (PG1249, fc 12.1), Hemmaglutinin 
(PG1602, fc 22.3), TonB-dependent OM receptor (PG0170, fc 285), and a hypothetical 
protein (PG0554, fc 50.7).  
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Fig 3.1. Phylogram of VimA, FemA, FemB & FemX  shows a close relationship of 
VimA to FemX 
Fig 3.2. Several consensus sequences are present in both VimA and FemX
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The terminal residues from the 15 missing extracellular proteins were examined 
to determine whether a common sequence was present in each. No common domain 
was present in all these proteins (Fig 3.4). Using PPSearch 
(http://www.ebi.ac.uk/Tools/ppsearch/), several common domains were identified in the 
fifteen extracellular proteins identified by MS analysis (Table 3.4.). Casein Kinase II 
phosphorylation motifs, Protein Kinase C motifs and myristolation motifs were most 
abundant. 
 
Complementation of the VimA Defect 
The VimA defect was complemented using a PCR mediated replacement 
strategy. Several black pigmented colonies were identified on blood agar plates after 
electroporation and incubation with the ORF of VimA, these were designated FLL92C, 
FLL92B and FLL92D. FLL92B and FLL92D was further characterized and shown to 
have the characteristic phenotype of W83. FLL92C became hemolytic and black 
pigmented much later than wild-type W83 (+5 days) and autoaggregated when 
incubated in BHI broth. Notable, its gingipain activity was marginally higher than FLL92 
in log phase. The VimA gene from this strain was sequenced in order to determine 
whether a mutation in the gene accounted for this phenotype. Two mutations were 
observed in FLL92C at positions 5 and 6, where CC was replaced by AG. The translated 
product of this gene contained valine rather than isoleucine at the third amino acid 
position.    
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Table 3.1. MS analysis of aberrantly expressed proteins in FLL92 extracellular 
fraction 
 
Identified Proteins (68) Accession 
# 
Putative          
Role/Function 
M.W. W83 
S.C.V 
FLL92 
S.C.V 
Hypothetical protein PG0027 Unknown 25 kDa 0 2 
UDP-3-O-acyl-GlcNAc deacetylase/(3R)-
hydroxymyristoyl-acp-dehydratase 
PG0060 Fatty acid 
biosynthesis 
52 kDa 0 3 
Nitrogen assimilation regulatory protein 
(immunoreactive 47 kD antigen PG120) 
PG0136 Transcription 47 kDa 0 12 
Endothelin converting enzyme/neprilysin 
(PepO) 
PG0146 Proteolysis 79 kDa 0 2 
NADH oxidase/peroxidase PG0160 Energy 
metabolism 
104 kDa 0 7 
Probable outer membrane protein (Omp85 
analog) 
PG0175 Cell envelope 102 kDa 0 5 
Uroporphyrinogen-III synthase PG0185 Biosynthesis of 
cofactors 
28 kDa 0 7 
Hypothetical protein PG0227 Unknown 11 kDa 0 4 
Translation initiation factor IF-2 PG0230 Translation 108 kDa 0 2 
Conserved hypothetical protein PG0264 Unknown 39 kDa 0 4 
Polyferredoxin PG0276 Energy 
metabolism 
30 kDa 0 2 
Probable dipeptidyl peptidase PG0291 Proteolysis 101 kDa 0 2 
Conserved hypothetical protein PG0293 Unknown 15 kDa 0 3 
DNA-mismatch repair protein PG0350 DNA metabolism 95 kDa 0 9 
DNA-directed RNA polymerase subunit beta PG0360 Transcription 142 kDa 0 2 
ATP-dependent DNA helicase PG0381 DNA metabolism 82 kDa 0 4 
ATP-dependent ClpX-related protease PG0382 Proteolysis 46 kDa 0 16 
Ferredoxin oxidoreductase beta subunit PG0394 Energy 
metabolism 
37 kDa 0 2 
Conserved hypothetical protein PG0411 Unknown 52 kDa 0 2 
Conserved hypothetical protein PG0452 Unknown 54 kDa 0 49 
Pyruvate ferredoxin/flavodoxin oxidoreductase PG0498 Energy 
metabolism 
132 kDa 0 2 
Hypothetical protein PG0510 Hypothetical 34 kDa 0 5 
Beta-galactosidase PG0598 Energy 
metabolism 
127 kDa 0 11 
DNA topoisomerase I PG0680 DNA metabolism 90 kDa 0 17 
Acyl-CoA dehydrogenase (coenzyme A 
dehydrogenase) 
PG0696 Metabolic 
process 
65 kDa 0 2 
Probable Xaa-Pro dipeptidase PG0795 Proteolysis 44 kDa 0 4 
Beta-galactosidase PG0799 Energy 
metabolism 
116 kDa 0 2 
Translation elongation factor G protein PG0832 Translation 80 kDa 0 2 
Calcium ion-transporting ATPase PG0838 Transport & 
binding 
118 kDa 0 2 
Threonyl-tRNA synthetase PG0888 Translation 75 kDa 0 7 
D-lysine 5,6-aminomutase alpha subunit PG0955 Energy 
metabolism 
57 kDa 0 6 
Butyryl-CoA dehydrogenase PG0958 Fatty acid 
metabolism 
42 kDa 0 7 
Alanine racemase; N-acetylymuramoylalanyl-D-
glutamate-2,6,-diaminopimelate-D-alanine-D-
alanine ligase 
PG0976 Cell envelope 92 kDa 0 2 
Conserved hypothetical protein PG0981 Unknown 107 kDa 0 9 
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Ribonucleotide reductase alpha subunit PG1010 DNA replication 96 kDa 0 6 
Probable long-chain fatty-acid-Coenzyme A 
ligase (long-chain acyl-CoA synthetase) 
PG1028 Metabolic 
processing 
69 kDa 0 3 
Transferase protein PG1029 Transposon 
functions 
43 kDa 0 7 
Xaa-Pro aminopeptidase PG1071 Proteolysis 67 kDa 0 14 
Hypothetical protein PG1089 Unknown 80 kDa 0 17 
GTP-binding protein (possible membrane 
protein) 
PG1097 Signal 
transduction 
66 kDa 0 2 
Conserved hypothetical protein PG1128 Unknown 47 kDa 0 5 
Thiol protease (PrtT related) PG1251 Proteolysis 93 kDa 0 2 
O-succinylbenzoate--CoA ligase PG1330 Biosynthesis of 
cofactors 
40 kDa 0 9 
Magnesium-protoporphyrin O-
methyltransferase; cobalamin biosynthesis  
protein N 
PG1359 Biosynthesis of 
cofactors 
163 kDa 0 2 
Aminomethyltransferase (glycine cleavage 
system T protein) 
PG1364 Energy 
metabolism 
40 kDa 0 16 
Nicotinate-nucleotide pyrophosphorylase 
(quinolinate phosphoribosyltransferase) 
PG1377 Biosynthesis of 
cofactors 
30 kDa 0 4 
Bacteroides aerotolerance operon protein, batD PG1385 Adaptations to 
atypical 
conditions 
67 kDa 0 2 
Fumarate reductase/succinate dehydrogenase 
flavoprotein subunit 
PG1413 Energy 
metabolism 
72 kDa 0 7 
Cell division protein (ATPase) PG1430 Cell division 96 kDa 0 2 
Hypothetical protein PG1448 Unknown 15 kDa 0 21 
Conserved hypothetical protein PG1496 Transport 99 kDa 0 2 
ABC transporter, ATP-binding protein, MsbA 
family; MSD-NBD fusion protein 
PG1497 Protein transport 
& binding 
70 kDa 0 4 
Hypothetical protein PG1504 Protein binding 53 kDa 0 2 
Immunoreactive 46 kDa antigen PG99 PG1572 Unknown 46 kDa 0 6 
Enolase (phosphopyruvate hydratase)(2-
phosphoglycerate dehydratase) (laminin 
binding protein) 
PG1593 Energy 
metabolism 
46 kDa 0 22 
Urocanate hydratase PG1630 Energy 
metabolism 
74 kDa 0 2 
Na+/H+-exchanging protein (Na+/H+ antiporter) PG1634 Transport & 
binding 
49 kDa 0 4 
Polyphosphate kinase PG1640 Polyphosphate 
biosynthesis 
81 kDa 0 3 
30S ribosomal protein S8 PG1677 Translation 15 kDa 0 4 
30S ribosomal protein S3 PG1684 Translation 28 kDa 0 2 
50S ribosomal protein L2 PG1687 Translation 30 kDa 0 3 
30S ribosomal protein S7 PG1693 Translation 18 kDa 0 2 
Hypothetical protein PG1783 Cell redox, 
homeostasis 
39 kDa 0 2 
LPS-modified surface protein P59 PG1838 Cell envelope 61 kDa 0 38 
Hypothetical protein PG1867 Unknown 51 kDa 0 19 
Hypothetical protein PG1899 Hypothetical 27 kDa 0 6 
Conserved hypothetical protein PG1927 Unknown 214 kDa 0 3 
Excinuclease ABC subunit A PG1934 DNA metabolism 106 kDa 0 6 
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Fig 4. Extracellular proteins with different S.C.V
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Fig. 3.3. Extracellular proteins with different S.C.V
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Table 3.2. MS analysis of missing proteins in FLL92 extracellular fraction 
 
Identified Proteins (15) Accession # Putative          
Role/Function 
M.W. W83 
S.C.V 
FLL92 
S.C.V 
Receptor antigen B PG0171 Cell envelope 56 kDa 231 0 
Conserved hypothetical protein PG0375 Translation 144 kDa 5 0 
Preprotein translocase subunit A 
protein 
PG0468 Protein targeting 126 kDa 5 0 
Glutamine-hydrolyzing carbamoyl-
phosphate synthase large subunit 
PG0484 Arginine 
biosynthesis 
120 kDa 3 0 
Hypothetical protein PG0552 Unknown 37 kDa 10 0 
Hypothetical protein PG0592 Unknown 45 kDa 29 0 
Heme-binding protein/peripheral outer 
membrane chelatase 
PG0602 Cell envelope 33 kDa 10 0 
Outer membrane protein PG0626 Cell envelope 42 kDa 10 0 
TonB-dependent receptor HmuY PG1357 Transport & 
binding 
16 kDa 9 0 
Probable integral outer membrane 
protein P20 
PG1592 Cell envelope 24 kDa 2 0 
Glyceraldehyde 3-phosphate 
dehydrogenase 
PG1857 Energy 
Metabolism 
36 kDa 2 0 
Conserved hypothetical protein PG1875 Unknown 123 kDa 3 0 
Hypothetical protein PG1894 Unknown 21 kDa 2 0 
Outer membrane protein PG1901 Cell envelope 32 kDa 7 0 
Conserved hypothetical protein PG1938 Unknown 61 kDa 7 0 
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Table 3.3.  Predicted post translational motifs in missing FLL92 extracellular 
proteins 
Proteins MYR 
* 
TYR_ 
PHO
CK2_
PHO
PKC_
PHO
CAMP_
PHOS 
ASN_
GLYC 
Amid
ation  
Unique  
PG0171 4 0 6 0 0 2 0 0 
PG0375 18 0 18 15 0 22 0 PTS-HPR 
Rib S2 
PG0468 7 0 20 23 3 4 4 ATP_GTP_A 
SECA 
PG0484 15  17 7 1 3 0 CPSASE 1 
CPSASE 2
PG0552 6 1 3 1 0 1 0 0 
PG0592 5 0 0 5 1 3 0 0 
PG0602 3 0 2 4 0 2 0 0 
PG0626 8 1 5 5 0 0 0 OMPA_1 
PG1357 2 0 1 6 0 0 1 ATP_GTP_A 
PG1592 8 0 2 4 0 1 0 0 
PG1615 4 0 5 3 2 2 0 0 
PG1857 7 0 8 5 1 3 0 GAPDH 
PG1875 16 0 17 19 2 7 0 RGD 
PG1894 5 1 1 0 0 0 1 0 
PG1901 1 0 3 5 1 2 1 0 
PG1938 23 0 5 8 0 4 0 0 
(MYR -N-myristoylation site, TYR_PHOS -Tyrosine kinase phosphorylation site, 
CK2_PHOS -Casein kinase II phosphorylation site,  PKC_PHOS - Protein kinase C 
phosphorylation site, CAMP_PHOS - cAMP and cGMP-dependent protein kinase 
phosphorylation site, ASN_GLYC - N-glycosylation site, Amidation - Amidation site, 
PTS-HPR - Serine Phosphorylation site signature, Rib S2 - Ribosomal protein S2 
signature, SECA - SecA Family signature, ATP_HPR - ATP/GTP-binding site motif 
A, CPSASE 1 -  Carbamoyl-phosphate synthase subdomain signature 1, CPSASE 2 
- Carbamoyl-phosphate synthase subdomain signature 2, OMPA_1 - OMPA-like 
domain, GAPDH - Glyceraldehyde 3-phosphate dehydrogenase active site, RGD – 
Cell attachment sequence) 
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Fig. 3.4. Sequence alignment of the 15 missing extracellular proteins in FLL92 
identified by Mass Spectrometric analysis. No unique sequence was common to all 
proteins. 
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Peptidoglycan from W83 is Hydrolyzed Faster than FLL92 
To determine whether the peptidoglycan of FLL92 was chemically dissimilar to 
that of FLL92, several lytic enzymes including lysozyme and lysostaphin were used (Fig 
3.8). No significant change was observed between the wild-type and FLL92 using 
lysozyme; however, with the lysostaphin treated peptidoglycan, the rate of hydrolysis in 
W83 was twice that observed in FLL92 (lifetime of W83 - 270.47 ± 21.6; lifetime of FLL92 – 
540.43 ± 82) 
 
The Murein Sacculi from FLL92 Differs from W83 
TEM and AFM were used to determine the morphology and topography of the 
peptidoglycan Sacculi. The Sacculi from FLL92 when compared to the wild-type was 
distinctly different, as it possessed a homogeneously uneven surface with numerous 
contours. Sacculi from W83 were on average 100nm longer than those observed in 
FLL92 (Fig. 3.6 and Fig. 3.7.). Murein sacculi from both strains was subsequently treated 
with 15µg/ml of lysostaphin for ten minutes and imaged via AFM. Treated W83 were 
visibly different from the untreated control, as numerous contours were visible on the 
surface. In FLL92, the morphology of the treated samples was similar to the control.  
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Fig. 3.5. Murein Sacculus Differs in FLL92 Compared to the wild-type 
 
Transmission Electron Microscopy (TEM) was used to visualize the peptidoglycan sacculi of W83 and FLL92 strains, grown to late
OD.  Morphological differences were observed in FLL92, when compared to W83 
 
W83 FLL92 
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W83 W83 
FLL92 FLL92 
Fig. 3.6. Sacculi Topography of W83 and FLL92 
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FLL92 Treated 
W83 Treated 
Fig. 3.7. Sacculi of W83 and FLL92, after 10min Treatment with 16μg/ml of Lysostaphin 
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Fig. 3.8. Peptidoglycan from W83 is Hydrolyzed Twice as Fast as FLL92 
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Discussion 
 In this study, we report that the peptidoglycan of FLL92 and the protein profile 
of the extracellular fraction are altered when compared to wild-type W83. VimA, a gene 
downstream of recA - encodes a 32 kDa protein. When inactivated, the phenotype of the 
mutant strain (FLL92) was non black pigmented, had reduced Arg-X and LysX specific 
proteolytic activity, lacked hemolytic and hemagglutinating activities, showed increased 
autoaggregation and was nonvirulent (1). Recently, the vimA gene was also shown to be 
involved in capsular and fimbrial biogenesis (33).  
The phylogenetic tree comparing VimA to the FemABX proteins, suggests that 
FemX (0.45) is closer in relation to VimA (0.52) than the other Fem proteins. Members of 
the FemABX family are novel ribosomal Peptidyl transferases that are involved in the 
interchain peptide bridges of the peptidoglycan. Though primarily found in Gram positive 
bacteria they are observed in a few Gram negative bacteria, particularly the pathogenic 
spirochetes (13,15,15). FemX catalyzes the transfer of L-Ala onto the cytoplasmic UDP-
N-acetylmuramyl-peptapetide (UDP-MurNAc-pentapetide) in contrast to the other Fem 
family members, which exclusively or preferentially transfers amino acids to membrane 
bound peptidoglycan precursors (28,36).   The Kinetics of the FemX involves the 
sequential binding of UDP-MurNAc-pentapeptide and the Ala-tRNA to FemX, followed 
by the transfer of Ala to the -amino group of L-Lys in the pentapeptide stem and the 
subsequent release of the UDP-MurNAc-hexapeptide reaction products and the tRNA 
(36).  
Several reports have indicated a role for the peptidoglycan in eliciting the host 
immune response (19,21); however, much remains unknown with regards the structural 
dynamics of the peptidoglycan in P. gingivalis and the enzymes involved in its 
biogenesis. Notably, there are no reported orthologs for the Fem family of proteins in P. 
gingivalis. The relative molar ratios of the glycan residues was previously reported to be 
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considerably lower in P. gingivalis when compared to Bacteroides spp, Pseudomonas, 
Actinobaccillus and Actinomycetes, suggestive of higher tetrapeptide to muramic acid 
ratios. The amino acid composition of this tetrapeptide contained Alanine, 
Diaminopimelicacid (DAP), Glycine and Lysine (17). Interestingly, previous studies in our 
lab have shown that recombinant VimA is able to interact with PG1101 (Alanyl t-RNA 
synthetase) (40). This finding is consistent with our in silico analysis, which suggests that 
VimA may have FemX function, as it would be expected to bind the Ala-tRNA and the 
UDP-MurNAc-pentapeptide. The conserved domains identified in both FemX and the 
VimA - RY*E**RO, KL****RDG****S, and EG*LL, may represent binding/interaction sites.   
 TEM and AFM microscopy showed morphological differences between W83 
and FLL92. The sacculi from FLL92 was on average shorter in length than those 
observed in FLL92, and these sacculi also appeared granular in contrast to the smooth 
topography present in the wild-type. When wild-type sacculi were treated with 
lysostaphin (endopeptidase which specifically cleaves pentaglycine cross bridges) for 
ten minutes, the surface of W83 showed signs of stress with several contours indicative 
of hydrolysis, while the FLL92 sacculi showed no discernable change. In peptidoglycan 
assays using Lysozyme (catalyzes the hydrolysis of 1, 4-beta-linkages between N-
acetylmuramic acid and N-acetyl-D glucosamine) the percentage of hydrolysis was 
unchanged for the wild-type and mutant. Using lysostaphin, the rate of hydrolysis was 
two times that of FLL92, suggesting that the peptidoglycan from W83 is more efficiently 
hydrolyzed than in FLL92. It is likely, that the vimA dependent modification of the 
peptidoglycan may contribute to a structural modification, which may lead to its relative 
resistance to lysostaphin. In bacteria, o-acetylation of the peptidoglycan can modulate 
turnover by reducing the activity of autolysins and endogenous enzymes (7,23,34). The 
levels of o-acetylation in P. gingivalis FLL92 and W83 are unclear and the subject of 
further investigation.  
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In a previous report (33), we established that the VimA affects several surface 
related structures including fimbriae, capsule and some outer membrane proteins. To 
clarify whether this alteration in the protein profile was unique to the outer membrane or 
affected all secreted proteins, mass spectrometry was performed on the extracellular 
fraction. Sixty-eight proteins were identified as being aberrantly expressed in FLL92 (i.e. 
missing from the extracellular fraction of W83), this was markedly more than that 
observed in the outer membrane fraction (n=20). Interestingly, PG1496 - a conserved 
hypothetical protein predicted to be involved in transport, is aberrantly expressed in the 
outer membrane and extracellular fraction. Two other proteins with protein transport and 
binding functions – PG1497 and PG1504, were also aberrantly expressed. It is likely that 
these three proteins are part of a novel transporter/cell sorting system in P. gingivalis, 
which when disrupted, results in alterations in secretion and anchorage of proteins. Of 
note is the fact that several cytoplasmic proteins were found in the extracellular fraction 
of FLL92, including those involved in energy metabolism, translation and DNA 
metabolism. Though we cannot definitively rule out the possibility of cytoplasmic 
contamination, the fact that these protein fractions were all prepared under the same 
conditions using the same techniques, coupled with the fact that they are absent from 
the wild-type fraction, which showed no contamination with the periplasmic marker used 
– PG0535 (HtrA), leads us to believe that these proteins are incorrectly targeted for 
secretion in FLL92. PG1857 – Glyceraldehyde 3 phosphate dehydrogenase, which is 
involved in the colonization of P. gingivalis (30), is the only protein that was found to be 
missing from both the membrane and extracellular fractions of FLL92. An examination of 
proteins with varying spectral count values, suggest that Kgp is 6 times as abundant in 
W83 compared with FLL92, while RgpA has a negative fold change of 1.2. In a previous 
report, we have demonstrated that the gingipains though transcriptionally unaltered, are 
translationally affected by the vimA mutation, exemplified by the secretion of the inactive 
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precursor forms of these proteases (39,40). These results demonstrate that the 
disruption of the VimA – gingipain maturation pathway does not only lead to different 
forms being secreted, but also affects the concentration of these products. This 
phenomenon was also evident for the TonB dependent OM protein (PG0170), 
Carboxypeptidase D (PG0212), Hemmaglutinin (PG1602) and the Peptidylarginine 
deiminase (PG1249)  
Several secreted proteins have been found to have primary and secondary 
structure similarity to the C-terminal domain of RgpB. These proteins have been 
designated the CTD family; and members of this family are attached to the cell surface 
through cell envelope glycans, which are important for proper folding and processing in 
order to produce a fully functional enzyme (37). In silico analysis was used to examine 
the C terminal of the missing extracellular proteins identified by mass spectrometry. We 
hypothesized that there would likely be a common motif unique to all these proteins; 
however, no common motif was present in missing proteins from the extracellular 
fraction, suggesting that a unique C terminal motif does not account for the alterations 
observed with the extracellular missing proteins.  
Taken together, our results demonstrate that the VimA of P. gingivalis is needed 
for the correct secretion of several extracellular proteins and is likely involved in 
peptidoglycan biogenesis. This latter finding is the focus of ongoing research in our 
laboratory. 
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CHAPTER FOUR 
DISCUSSION 
 
 P. gingivalis has several surface components that contribute to its virulence; 
these include - fimbriae, major outer membrane proteins, hemagglutinin, lipid 
polysaccharides, capsule and gingipains (5,24). Several genes - vimA, vimE, vimF, 
porR, rfa and ugdA (10,11,15,16,19-21) have been reported by our lab and others to be 
implicated in the formation of extracellular polysaccharides as well as glycan addition of 
gingipain-adhesin complexes (12). It nevertheless remains uncertain, whether the 
phenotypic change produced by mutations of these genes is due to the interruption of a 
central pathway, or multiple pathways.     
The VimA which encodes a 32-kDa protein, was the first gene identified in our 
lab that showed the ability to modulate proteolytic activity. The phenotype of the vimA 
mutant strain (FLL92) when compared with the wild-type parent strain W83, was: non-
black pigmented, non-virulent, had reduced hemagglutinating, hemolytic and proteolytic 
activity, showed increased autoaggregation and had a truncated LPS (10,21).  The 
protein profile of FLL92 was also markedly different when compared to W83. Taken 
together, these results suggest that VimA plays a central role in the regulation and 
biogenesis of several surface structures and proteins. In this report, we address 
particular gaps in our understanding (Fig. 4.1.), regarding the role of VimA in capsular 
and fimbrial biogenesis, protein sorting and anchorage, acylation and glycosylation of 
outer membrane proteins, as well as its likely role in peptidoglycan biogenesis.  
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The VimA was predicted by in silico analysis to be closely related to the FemABX 
family of proteins. These proteins are found primarily in Gram positive bacteria and are 
involved in peptidoglycan biosynthesis (1,6,18). An examination of the phylogeny 
suggested that VimA (0.52) is closest in relation to the FemX (0.45). Notably, the FemX  
differs from the FemA and FemB which preferentially transfers amino acids to 
membrane bound peptidoglycan precursors, in that it catalyzes the transfer of L-Ala onto 
the cytoplasmic UDP-N-acetylmuramyl-peptapetide (UDP-MurNAc-pentapetide) (8,13). 
This process involves the sequential binding of Ala-tRNA and the UDP-MurNAc-
pentapeptide. The ability of VimA to bind PG1101 (22), an Alanyl tRNA synthetase, 
further supports this function. Several attempts have been made to localize the VimA 
protein, using antibodies raised against the over expressed E. coli protein, this strategy 
has thus far proven unsuccessful, however there is evidence (unpublished) to indicate 
that this protein is likely cytoplasmic or periplasmic. 
The role of VimA in peptidoglycan biogenesis was examined using TEM, AFM 
and hydrolytic enzyme assays. The peptidoglycan sacculi from FLL92 was distinctly 
different from that of W83, and had a granular appearance with numerous fine 
structures; additionally, peptidoglycan from FLL92 was hydrolyzed at a slower rate than 
W83. Taken together, our findings indicate a role for VimA in peptidoglycan biogenesis. 
Functional assays to demonstrate the ability of VimA to transfer Alanyl from a tRNA 
synthetase to the peptidoglycan are presently being pursued, as are experiments aimed 
at determining the difference in the peptide component of the peptidoglycan in FLL92 
compared to W83.  
Two separate superfamily prediction software yielded two likely classifications for 
the VimA. VimA was predicted to belong to the DUF482/CH1444 and/or the Acyl CoA N-
acyltransferase superfamily. The DUF482/CH1444 family is part of the PEP-CTERM 
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system that has sortase like function (4) – involved in proteins sorting, while the Acyl 
CoA N-acyltransferase superfamily is a broad family which includes the FemABX 
nonribosomal peptidyltransferases family. The VimA was also predicted to interact with 
several proteins including RgpB, which is consistent with previous reports demonstrating 
the ability of VimA to interact with the gingipains (22). 
Several reports have suggested that a correlation exists between fimbrial and 
capsular synthesis and the autoaggregation phenotype observed in P. gingivalis  (3). 
This led us to hypothesize that the vimA mutation could effect capsular and fimbrial 
biogenesis. Transmission Electron Microscopy and Atomic Force Microscopy revealed 
that the capsule of FLL92 was irregular and fuzzy compared to the solid well defined 
capsule of the wild-type; additionally, FLL92 had a corrugated topography compared to 
with the smooth morphology present in W83. There was also increased fimbrial 
detection via immunogold staining and immunoblotting. Since the transcription level of 
fimA was unchanged in the mutant compared to the wild-type, hypothesize that the 
expression of capsular polysaccharides may impede the phenotypic expression of 
fimbriae, in a manner similar to that demonstrated in Klebsiella pneumoniae (7,14), i.e. 
direct physical interaction might impede the polymerization of fimbriae on the cell surface 
(Fig. 4.2.). These findings are in contradiction to a recent report which suggests, that the 
inability of W83 to produce fimbriae is due to a mutated FimSR histidine kinase and the 
inability of W83 FimA to polymerize on the outer membrane of the cell (9). Our findings 
suggest that an alternate FimSR independent pathway may exist for fimbrial maturation. 
Further studies are needed to determine whether the VimA plays a direct role in the 
synthesis and regulation of these two macro-structures, and the degree of FimA 
polymerization in the mutant. 
 Mass spectrometry was performed on proteins from the membrane and 
extracellular fractions of FLL92, in order to determine the types of proteins that were 
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being affected by the VimA mutation, and to elucidate whether the VimA could have 
sortase-like function.  In the membrane fraction of FLL92, twenty proteins were identified 
as aberrantly anchored to the cell wall of FLL92, while nine proteins were missing. 
Twenty proteins had variable spectral count values (normalized spectral count values 
correspond to the relative abundance of the protein). In the extracellular fraction, sixty 
eight proteins were identified as aberrantly expressed, while fifteen proteins were 
missing and 20 had variable spectral count values.  
The absence of Carboxypeptidase D on the outer membrane of FLL92 likely 
explains why Kgp and RgpA are not anchored to the outer membrane, as these 
enzymes require C terminal processing (2,23). Interestingly, this enzyme is present at 
lower abundance in the extracellular fraction of FLL92 Compared with W83 - negative 
fold change of 28. Several transport proteins and several structural membrane proteins 
are aberrantly expressed or missing in this mutant. It is likely, that the absence of these 
transport and structural proteins result in a disruption in the normal cell sorting and 
secretion machinery, resulting in incorrect and unregulated protein secretion. Mass 
spectrometry also confirmed our previous finding (21,22) that RgpA and Kgp are only 
found in the extracellular fraction of FLL92; notably however, these gingipains are at 
much lower levels of abundance. RgpA showed a negative fold change of 1.2, while Kgp 
had a negative fold change of 6.6.  Taken together, these findings support a role for 
VimA in anchorage and maturation of outer membrane proteins and the correct targeting 
of secreted proteins. The interaction between VimA and the missing or aberrantly 
expressed outer membrane and extracellular proteins, is an active area of investigation.  
Previous reports in our lab have highlighted the aberrant protein glycosylation 
that occurs in FLL92 (21); however, not much is known about the particular carbohydrate 
moieties involved in this aberrant glycosylation profile. Lectin binding assays allowed for 
the identification of these moieties. Outer membrane proteins glycosylated with 
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Galactose (β 1,3) N-Acetylgalactosamine, N-acetyl-α-D-galactosamine, Galactose (β 
1,4) N-Acetylglucosamine, N-acetyl-D-galactosamine and Sialic Acid (N-Acetyl neuramic 
acid) were affected by the vimA mutation. These findings indicate a role for VimA in the 
correct glycosylation of membrane proteins. 
Lipid modification of outer-membrane proteins in P. gingivalis has been well 
characterized (17), based on the characterization of VimA (A putative acyl transferase), 
we hypothesized that it would play a role in the acylation of one or more membrane 
proteins. Using 3H labeled palmitic acid as the lipid donor, the role of VimA was 
examined. No changes were observed in the lipid modified protein profile of the wild-type 
total protein fraction. Comparatively, distinct differences were observed in the 
extracellular fraction of FLL92 when compared with W83. A 54 kDa protein was three 
times more abundant in W83 than in FLL92, while a 27 kDA protein was twice as 
abundant in FLL92 compared with W83. These results suggest that the VimA is 
important for the correct acylation of a 54 kDa protein in the extracellular fraction, or that 
acylation may be required for dimerization of the 27 kDa protein. Several studies are 
presently ongoing with a view to clarify this observation.  
Our findings support the view that VimA is a multifunctional – multi domain 
protein, involved in the regulation of membrane components including – fimbriae, 
capsule, and peptidoglycan. This protein is also involved in the sorting and secretion of 
several proteins and plays a role in the correct glycosylation of several outer membrane 
proteins and the correct acylation of at least two secreted proteins. Our results indicate a 
putative central role for the VimA protein in membrane biogenesis, protein modification 
and transport. These putative multiple functions require further elucidation.  
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